https://curecurrent.com/trials/ayurvedic-management-of-chronic-kidney-disease-15001https://curecurrent.com/trials/idg-16177-for-the-evaluation-of-its-safety-and-pharmacokinetics-15002https://curecurrent.com/trials/hyperglycemia-and-pre-diabetes-in-pediatric-renal-and-liver-transplantation-15003https://curecurrent.com/trials/measuring-svap-1-as-a-predictor-of-pregnancy-problems-15004https://curecurrent.com/trials/vitamin-d-metabolism-in-patients-with-endocrine-disorders-15005https://curecurrent.com/trials/clinical-analysis-of-simultaneous-pancreas-kidney-transplantation-for-end-stage-renal-disease-associated-with-diabetes-m-15006https://curecurrent.com/trials/exercise-therapy-for-people-with-a-diabetic-foot-ulcer-a-feasibility-study-15007https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-immunomodulation-with-at-1501-in-islet-cell-transplantation-15008https://curecurrent.com/trials/effect-of-corona-virus-on-intravitreal-injections-15009https://curecurrent.com/trials/the-effectiveness-of-stingless-bee-honey-kelulut-honey-versus-gel-in-diabetic-wound-bed-preparation-15010https://curecurrent.com/trials/continuous-glucose-monitoring-for-women-with-diabetes-mellitus-in-the-intrapartum-and-postpartum-inpatient-care-15011https://curecurrent.com/trials/magnetic-resonance-imaging-in-high-risk-patients-for-the-development-of-diffuse-idiopathic-skeletal-hyperostosis-dish-15012https://curecurrent.com/trials/effect-of-live-combined-bifidobacterium-and-lactobacillus-on-glycemic-control-and-other-outcomes-in-type-1-diabetes-15013https://curecurrent.com/trials/patients-perceptions-of-using-the-libre-system-compared-with-conventional-smbg-in-adolescents-with-type-1-diabetes-the-l-15014https://curecurrent.com/trials/active-communities-adherence-to-physical-activity-15015https://curecurrent.com/trials/effects-of-moderate-physical-activity-on-early-symptoms-of-peripheral-diabetic-neuropathy-in-type-ii-diabetes-a-randomiz-15016https://curecurrent.com/trials/optimizing-gestational-weight-gain-for-prevention-of-gestational-diabetes-mellitus-in-malaysia-15017https://curecurrent.com/trials/medication-following-bariatric-surgery-for-type-2-diabetes-mellitus-15018https://curecurrent.com/trials/effect-of-high-dose-nac-on-patients-with-dpn-15019https://curecurrent.com/trials/efficacy-and-safety-of-berlim-25-10-association-in-the-treatment-of-type-ii-diabetes-mellitus-and-dyslipidemia-15020https://curecurrent.com/trials/serum-endocan-levels-and-gestational-diabetes-15021https://curecurrent.com/trials/efficacy-of-once-weekly-glp-1-analogue-semaglutide-a-multicenter-experience-from-pakistan-15022https://curecurrent.com/trials/intact-trial-an-observational-study-to-assess-neuropathy-in-diabetic-children-15023https://curecurrent.com/trials/early-assessment-of-impaired-cardiac-function-in-patients-with-diabetes-mellitus-15024https://curecurrent.com/trials/assessment-of-the-accuracy-of-continuous-glucose-sensors-in-people-with-diabetes-undergoing-haemodialysis-15025https://curecurrent.com/trials/the-value-of-second-trimester-uterine-artery-doppler-analysis-in-the-prediction-of-gdm-in-a-low-risk-population-15026https://curecurrent.com/trials/carbohydrates-distribution-in-pregnancy-study-15027https://curecurrent.com/trials/pharmacists-interventions-on-patients-diabetic-and-obese-patients-in-the-uae-randomized-controlled-trials-15028https://curecurrent.com/trials/study-about-adherence-and-tolerance-of-an-oral-nutritional-supplement-ons-specific-for-diabetic-patient-15029https://curecurrent.com/trials/diagnostic-analysis-of-oral-glucose-tolerance-test-in-early-pregnancy-for-gestational-diabetes-mellitus-15030https://curecurrent.com/trials/effect-of-education-based-on-the-health-belief-model-on-healthy-lifestyle-behaviors-in-individuals-with-type-2-diabetes-15031https://curecurrent.com/trials/molecular-mechanisms-and-carotid-atherosclerosis-15032https://curecurrent.com/trials/efficacy-and-safety-of-one-anastomosis-versus-roux-en-y-gastric-bypass-for-type-2-diabetes-remission-15033https://curecurrent.com/trials/symbiotics-and-systemic-inflammation-in-chronic-kidney-disease-15034https://curecurrent.com/trials/conditions-associated-with-poorly-controlled-diabetes-in-patients-with-type-2-diabetes-and-hba1c-changes-with-therapy-15035https://curecurrent.com/trials/physical-exercise-prescription-with-pedometer-in-general-practice-for-patients-with-cardiovascular-risk-factors-pepper-15036https://curecurrent.com/trials/pharmacogenetics-of-sglt2-inhibitors-15037https://curecurrent.com/trials/kids-diabetes-telemedicine-study-kites-15038https://curecurrent.com/trials/metabolic-inflexibility-of-the-heart-as-a-predictor-of-occurrence-of-heart-failure-in-patients-with-type-2-diabetes-15039https://curecurrent.com/trials/establishment-of-the-human-intestinal-and-salivary-microbiota-biobank-kidney-diseases-15040https://curecurrent.com/trials/safety-and-effectiveness-of-propagermanium-in-diabetic-kidney-disease-participants-receiving-irbesartan-15041https://curecurrent.com/trials/psychiatric-disorders-related-to-diabetes-mellitus-type-1-among-children-in-egypt-15042https://curecurrent.com/trials/low-carbohydrate-diet-and-automated-insulin-delivery-system-for-type-1-diabetes-15043https://curecurrent.com/trials/evaluation-of-sglt2-i-effectivness-and-safety-in-elderly-type-2-diabetes-patients-15044https://curecurrent.com/trials/assessment-of-glucose-concentrations-in-people-without-diabetes-mellitus-after-standardized-meals-and-in-daily-life-15045https://curecurrent.com/trials/hematocrit-effect-on-a-blood-glucose-monitor-15046https://curecurrent.com/trials/psychiatric-disorders-related-to-diabetes-mellitus-type-1-15047https://curecurrent.com/trials/individualized-technological-interventions-for-diabetes-care-in-the-covid-19-ward-15048https://curecurrent.com/trials/validity-of-turkish-version-of-abc-scale-in-diabetes-mellitus-patients-15049https://curecurrent.com/trials/effect-of-automated-insulin-delivery-on-early-stage-diabetic-complications-15050https://curecurrent.com/trials/randomized-clinical-trial-of-lifestyle-interventions-to-prevent-diabetes-in-women-with-previous-gestational-diabetes-15051https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-after-administration-of-br3003-and-co-administration-of-br3003b-and-br3003c-15052https://curecurrent.com/trials/the-association-between-body-constitution-and-meridian-energy-in-prediabetes-15053https://curecurrent.com/trials/efficacy-and-safety-of-lima-association-in-the-control-of-type-ii-diabetes-mellitus-15054https://curecurrent.com/trials/pilot-study-evaluating-safety-of-exolin-in-patients-with-poorly-controlled-type-1-diabetes-15055https://curecurrent.com/trials/clinical-trial-of-abluminus-des-sirolimus-eluting-stent-versus-everolimus-eluting-des-15056https://curecurrent.com/trials/association-of-bisphenol-a-paraben-exposure-and-type-2-diabetes-15057https://curecurrent.com/trials/impact-of-therapeutic-education-being-set-up-under-the-authorized-program-for-diabetics-patients-in-hospital-15058https://curecurrent.com/trials/the-effect-of-online-training-on-foot-care-15059https://curecurrent.com/trials/effects-of-pioglitazone-and-evogliptin-on-hepatic-fibrosis-in-patients-with-chronic-hepatitis-b-with-type-2-diabetes-15060https://curecurrent.com/trials/sensor-augmented-pump-versus-multiple-daily-injections-with-degludec-as-basal-insulin-for-insulin-therapy-in-type-1-diab-15061https://curecurrent.com/trials/fetal-growth-and-placental-function-in-pregnancies-complicated-by-diabetes-15062https://curecurrent.com/trials/cognitive-protective-effect-of-newer-antidiabetic-drugs-15063https://curecurrent.com/trials/study-of-acceptability-of-a-new-distance-learning-tool-myfit-15064https://curecurrent.com/trials/effects-of-dorzagliatin-on-1st-phase-insulin-and-beta-cell-glucose-sensitivity-in-t2d-and-monogenic-diabetes-15065https://curecurrent.com/trials/wound-infection-detection-evaluation-wide-15066https://curecurrent.com/trials/effect-of-tofogliflozin-on-uacr-compared-to-metformin-hydrochloride-in-diabetic-kidney-disease-truth-dkd-15067https://curecurrent.com/trials/identifying-risk-factors-for-developing-aki-in-sepsis-15068https://curecurrent.com/trials/cinnamomum-cassia-effect-on-igf1-and-metabolic-control-in-patients-with-dm2-without-glycemic-control-metformin-treated-15069https://curecurrent.com/trials/epigenetic-and-microbiota-modifications-15070https://curecurrent.com/trials/vitamin-d-and-painful-diabetic-neuropathy-15071https://curecurrent.com/trials/efficacy-and-safety-of-iglarlixi-versus-insulin-glargine-plus-dulaglutide-in-patients-with-type-2-diabetes-15072https://curecurrent.com/trials/head-to-head-comparison-of-empagliflozin-and-dapagliflozin-15073https://curecurrent.com/trials/short-message-service-for-type-2-diabetes-15074https://curecurrent.com/trials/effects-of-tcm-on-beta-cell-function-and-insulin-resistance-in-high-risk-chinese-individuals-for-t2d-tcm-pdiab-p01-15075https://curecurrent.com/trials/htems-treatment-of-diabetic-polyneuropathy-15076https://curecurrent.com/trials/empagliflozin-based-quadruple-therapy-vs-basal-insulin-based-therapy-15077https://curecurrent.com/trials/acupuncture-and-insulin-doses-in-insulin-treated-type-2-diabetes-15078https://curecurrent.com/trials/glycemic-index-of-pasta-from-traditional-and-current-wheat-varieties-15079https://curecurrent.com/trials/precision-medicine-in-chinese-patients-with-young-onset-diabetes-15080https://curecurrent.com/trials/digital-blended-lifestyle-intervention-for-type-2-diabetes-remission-15081https://curecurrent.com/trials/study-of-the-genome-gut-metagenome-and-lifestyle-of-patients-with-incident-type-2-diabetes-mellitus-15082https://curecurrent.com/trials/digital-3d-reconstruction-predicts-small-bowel-length-15083https://curecurrent.com/trials/study-of-hiv-infected-and-uninfected-pregnant-woman-child-dyads-in-gaborone-botswana-15084https://curecurrent.com/trials/clinical-effects-of-intermitent-continuous-glucose-monitoring-in-type-1-diabetes-15085https://curecurrent.com/trials/effects-of-seaweed-extract-on-blood-glucose-response-to-sucrose-15086https://curecurrent.com/trials/a-study-of-hs-20094-in-healthy-participants-15087https://curecurrent.com/trials/evaluation-of-insulin-glargine-lixisenatide-fixed-ratio-combination-in-patients-with-type-2-diabetes-insufficiently-cont-15088https://curecurrent.com/trials/sleep-extension-and-insulin-sensitivity-in-adolescents-15089https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-insulin-glargine-lixisenatide-fixed-ratio-combination-to-insulin-glargine-in-pa-15090https://curecurrent.com/trials/eastern-caribbean-health-outcomes-research-network-echorn-15091https://curecurrent.com/trials/incidence-of-hypoglycaemia-events-in-patients-with-stable-insulin-treated-type-2-diabetes-mellitus-based-on-continuous-g-15092https://curecurrent.com/trials/diabetic-foot-care-and-limb-preservation-pathway-developmental-evaluation-study-15093https://curecurrent.com/trials/screening-for-genetic-forms-of-diabetes-in-convention-of-care-for-children-and-adolescents-with-diabetes-genepediab-15094https://curecurrent.com/trials/flash-continous-glucose-monitoring-in-transition-to-outpatient-libre-for-type-2-diabetes-mellitus-control-dm-15095https://curecurrent.com/trials/chronic-kidney-disease-and-cardiovascular-disease-risk-assessment-15096https://curecurrent.com/trials/the-early-warning-system-for-the-diabetic-encephalopathy-15097https://curecurrent.com/trials/correlation-of-hba1c-with-electrophysiological-studies-and-gait-performance-in-diabetic-polyneuropathy-patients-15098https://curecurrent.com/trials/avoidable-hospitalizations-emergency-department-visits-systematic-review-and-meta-synthesis-of-qualitative-research-15099https://curecurrent.com/trials/neurocognitive-performance-during-hyperglycemia-and-brain-tissue-integrity-in-youth-with-type-1-diabetes-and-in-healthy-15100https://curecurrent.com/trials/a-multicenter-clinical-study-of-echocardiographic-assessment-of-right-heart-function-and-implications-of-prognosis-in-di-15101https://curecurrent.com/trials/salivary-c1p-and-pge2-levels-in-periodontitis-patients-with-t2dm-and-effect-of-non-surgical-periodontal-treatment-15102https://curecurrent.com/trials/l-cell-activity-in-small-intestine-as-biliopancreatic-loop-in-obese-patients-with-dm2-submitted-to-rygbp-15103https://curecurrent.com/trials/a-comparative-study-of-the-effect-of-ayurvedic-drugs-and-metformin-in-the-management-of-diabetes-mellitus-type-ii-15104https://curecurrent.com/trials/the-influence-of-pulse-synchronized-negative-pressure-on-the-dermal-microcirculation-15105https://curecurrent.com/trials/macro-and-microvascular-response-to-cocoa-flavanols-in-healthy-and-type-2-diabetes-15106https://curecurrent.com/trials/singapore-healthy-alternative-protein-evaluation-study-15107https://curecurrent.com/trials/digital-foot-self-management-program-for-older-diabetes-15108https://curecurrent.com/trials/professional-continuous-glucose-monitoring-at-the-parkland-diabetes-clinic-15109https://curecurrent.com/trials/cohort-study-of-patients-with-type-1-diabetes-15110https://curecurrent.com/trials/insulin-iontophoresis-mixed-with-oleic-acid-versus-topical-insulin-in-patients-with-chronic-diabetic-foot-ulcer-15111https://curecurrent.com/trials/serum-ykl-40-level-and-platelets-indices-among-patients-with-diabetic-erectile-dysfunction-15112https://curecurrent.com/trials/laser-biostimulation-in-periodontal-treatment-15113https://curecurrent.com/trials/concentrated-cross-disciplinary-group-intervention-for-common-health-complaints-including-post-covid-19-fatigue-15114https://curecurrent.com/trials/phase-1-bioequivalence-study-of-dapagliflozin-sitagliptin-fdc-vs-loose-combination-of-single-components-15115https://curecurrent.com/trials/assessment-of-compliance-with-european-and-french-guidelines-for-the-management-of-dyslipidaemias-15116https://curecurrent.com/trials/expected-normal-ketone-values-after-very-low-and-bariatric-surgery-15117https://curecurrent.com/trials/step-up-for-health-study-a-pedometer-and-website-intervention-in-those-with-prediabetes-15118https://curecurrent.com/trials/effects-of-dapagliflozin-and-metformin-on-vascular-function-in-newly-diagnosed-treatment-naive-type-2-diabetes-15119https://curecurrent.com/trials/tenelia-elderly-cgms-study-teddy-15120https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-curalin-as-add-on-therapy-in-adults-with-type-2-diabetes-mellitus-15121https://curecurrent.com/trials/abo-glyc-in-type-2-diabetes-15122https://curecurrent.com/trials/effect-of-topical-antioxidants-in-dry-eye-disease-and-diabetic-retinopathy-15123https://curecurrent.com/trials/protocol-for-self-compassion-intervention-for-teens-with-diabetes-type-1-and-their-caregivers-15124https://curecurrent.com/trials/role-of-carnosine-in-combination-with-vitamin-b-complex-in-preventing-the-progression-of-diabetic-neuropathy-in-type-2-d-15125https://curecurrent.com/trials/phenotypic-and-genotypic-characterization-of-new-onset-type-i-diabetes-15126https://curecurrent.com/trials/the-potential-of-carnosine-supplementation-in-optimising-cardiometabolic-health-15127https://curecurrent.com/trials/evaluation-of-pharmacokinetics-safety-tolerability-and-pharmacodynamics-of-biocon-insulin-tregopil-15128https://curecurrent.com/trials/health-economic-analysis-of-islet-cell-transplantation-for-the-stabilization-of-the-severe-forms-of-type-1-diabetes-15129https://curecurrent.com/trials/a-trial-to-assess-the-efficacy-and-safety-of-m1-pram-p037-prandial-insulin-in-subjects-with-type-1-diabetes-t1dm-15130https://curecurrent.com/trials/rt-cgm-in-young-adults-at-risk-of-dka-15131https://curecurrent.com/trials/real-world-study-comparing-the-adherence-and-effectiveness-of-linagliptin-vs-acarbose-15132https://curecurrent.com/trials/roux-en-y-gastric-bypass-for-bmi-27-32-type-2-diabetes-versus-best-medical-treatment-15133https://curecurrent.com/trials/the-effect-of-metformin-and-dpp4-inhibitors-on-cognition-and-cardiovascular-protection-in-type-2-diabetic-patients-15134https://curecurrent.com/trials/effect-of-exercise-on-gdf-15-levels-in-prediabetic-patients-15135https://curecurrent.com/trials/study-of-the-value-of-using-a-honey-dressing-compared-to-the-use-of-a-standard-dressing-on-the-toe-amputation-wound-in-t-15136https://curecurrent.com/trials/remotely-monitored-exercise-program-in-pregnant-women-with-obesity-15137https://curecurrent.com/trials/the-effect-of-exercise-and-metformin-on-carotid-intima-media-thickness-in-patients-with-prediabetes-15138https://curecurrent.com/trials/effect-of-time-restricted-eating-on-blood-glucose-and-behavior-in-patients-with-type-2-diabetes-mellitus-15139https://curecurrent.com/trials/cologne-placenta-cohort-cpc-15140https://curecurrent.com/trials/glp1-imaging-before-and-after-bariatric-surgery-15141https://curecurrent.com/trials/efficacy-of-two-ons-in-patients-at-nutritional-risk-with-type-2-diabetes-mellitus-15142https://curecurrent.com/trials/a-mediterranean-intervention-on-prediabetic-children-15143https://curecurrent.com/trials/multi-organ-denervation-with-the-irf-system-to-reduce-sympathetic-drive-15144https://curecurrent.com/trials/the-efficacy-and-safety-of-different-doses-of-sy-009-in-patients-with-type-2-diabetes-mellitus-15145https://curecurrent.com/trials/prevention-of-gestational-diabetes-mellitus-with-lifestyle-intervention-among-women-of-advanced-maternal-age-15146https://curecurrent.com/trials/metformin-s-effect-on-drug-metabolism-in-patients-with-type-2-diabetes-15147https://curecurrent.com/trials/physical-activity-drop-out-ratio-in-patients-living-with-type-2-diabetes-15148https://curecurrent.com/trials/diabetes-mellitus-and-pregnancy-knowledge-assessment-15149https://curecurrent.com/trials/a-clinical-study-on-the-effect-of-hypoglycemic-drugs-on-the-prognosis-of-spinal-surgery-in-diabetic-patients-15150https://curecurrent.com/trials/time-in-range-tir-and-time-below-range-tbr-in-insulin-treated-elderly-patients-with-type-2-diabetes-15151https://curecurrent.com/trials/vitamin-d-k2-plus-empagliflozin-combination-in-type-two-diabetes-mellitus-15152https://curecurrent.com/trials/chinese-smartphone-app-for-6-18-years-with-t1dm-rct-15153https://curecurrent.com/trials/huangqi-guizhi-wuwu-decoction-in-ckd-stage-2-4-diabetic-nephropathy-15154https://curecurrent.com/trials/the-effects-of-dapagliflozin-in-normal-clinical-practice-in-t2d-15155https://curecurrent.com/trials/ozurdex-in-reducing-pvr-after-vitreotomy-in-pdr-15156https://curecurrent.com/trials/study-of-cbme-in-the-relief-of-painful-diabetic-neuropathy-15157https://curecurrent.com/trials/a-study-of-tg103-injection-in-type-2-diabetes-subjects-15158https://curecurrent.com/trials/effect-of-sglt2i-on-diabetic-retinopathy-in-type-2-diabetes-mellitus-patients-15159https://curecurrent.com/trials/impaired-gustatory-sensory-perception-in-obese-and-obese-diabetic-persons-15160https://curecurrent.com/trials/discovering-treatment-reality-of-type-2-diabetes-in-real-world-settings-15161https://curecurrent.com/trials/diabetes-prevention-program-metfit-in-reducing-insulin-resistance-in-stage-i-iii-breast-cancer-survivors-15162https://curecurrent.com/trials/fecal-microbiota-transplantation-for-early-clostridioides-difficile-infection-15163https://curecurrent.com/trials/effect-of-nutritional-supplements-on-clinical-outcomes-in-patients-with-prediabetes-and-obesity-15164https://curecurrent.com/trials/family-based-behavioral-medical-nutrition-therapy-education-in-children-and-adolescents-with-type-1-diabetes-15165https://curecurrent.com/trials/testosterone-for-peripheral-vascular-disease-15166https://curecurrent.com/trials/diabetes-foot-care-clinical-pathway-orpyx-medical-technologies-15167https://curecurrent.com/trials/application-of-s26e-for-diabetic-foot-ulcer-healing-15168https://curecurrent.com/trials/humalog-mix50-50-tm-as-a-treatment-for-gestational-diabetes-15169https://curecurrent.com/trials/effect-of-sglt2i-in-conjunction-with-the-artificial-pancreas-on-improving-the-glycemia-in-t1dm-in-the-outpatient-setting-15170https://curecurrent.com/trials/modified-foot-exercise-to-improve-sensitivity-and-perfussion-on-type-2-diabetes-patients-15171https://curecurrent.com/trials/efficacy-of-dapagliflozin-in-diabetes-associated-peripheral-neuropathy-15172https://curecurrent.com/trials/postprandial-gut-hormone-responses-in-patients-with-type-1-diabetes-mellitus-15173https://curecurrent.com/trials/kurcosmart-effects-on-people-with-type-2-dm-15174https://curecurrent.com/trials/steno-diabetes-dialogue-cards-teaching-on-group-education-on-blood-sugar-control-in-adolescents-with-type-1-diabetes-15175https://curecurrent.com/trials/effect-of-selenium-supplementation-on-glycemic-control-in-patients-with-type-2-diabetes-or-prediabetes-15176https://curecurrent.com/trials/a-prospective-cohort-study-for-establishing-clinical-excellence-in-patients-with-newly-diagnosed-type-1-and-type-2-diabe-15177https://curecurrent.com/trials/accuracy-of-cgm-in-the-icu-compared-to-standard-of-care-15178https://curecurrent.com/trials/the-effects-of-pilates-on-functional-capacity-and-blood-glucose-levels-in-adults-with-diabetes-type-2-15179https://curecurrent.com/trials/non-surgical-therapy-of-periodontitis-in-diabetes-patients-the-adjunctive-use-of-probiotics-15180https://curecurrent.com/trials/cohort-study-of-patients-with-type-1-diabetes-registered-with-mobile-application-in-china-15181https://curecurrent.com/trials/assessment-of-fetal-pancreatic-size-and-maternal-serum-biomarkers-in-gdm-15182https://curecurrent.com/trials/clinical-study-on-the-effect-of-a-synbiotic-on-body-fat-mass-15183https://curecurrent.com/trials/clinical-trial-to-assess-the-efficacy-and-safety-of-yyc405-in-type-2-diabetes-patients-15184https://curecurrent.com/trials/safety-and-efficacy-of-dapagliflozin-in-asian-t2dm-subjects-with-inadequate-glycemic-control-on-metformin-saxagliptin-15185https://curecurrent.com/trials/closed-loop-in-adults-with-t2d-not-requiring-dialysis-15186https://curecurrent.com/trials/laser-therapy-combined-with-intravitreal-aflibercept-vs-intravitreal-aflibercept-monotherapy-ladamo-15187https://curecurrent.com/trials/the-effect-on-metabolism-food-intake-and-preferences-of-a-knockout-gene-variant-involved-in-carbohydrate-metabolism-15188https://curecurrent.com/trials/prevalence-of-periodontitis-in-diabetic-patients-of-egyptian-population-15189https://curecurrent.com/trials/to-improve-the-ability-of-early-screening-and-diagnosis-in-patients-with-diabetic-nephropathy-15190https://curecurrent.com/trials/hepatic-and-cardiac-metabolic-flexibility-in-subjects-with-t2dm-with-and-without-nafld-15191https://curecurrent.com/trials/abnormal-plantar-pressure-in-patients-with-diabetes-15192https://curecurrent.com/trials/metformin-and-its-impact-on-the-substances-associated-with-no-production-in-prediabetes-patients-15193https://curecurrent.com/trials/evaluation-of-antiplatelet-effects-of-different-dosages-of-aspirin-in-type-2-diabetic-patients-15194https://curecurrent.com/trials/effects-of-insulin-treatment-on-postprandial-platelet-activation-in-patients-with-non-insulin-dependent-diabetes-mellitu-15195https://curecurrent.com/trials/e-clair-efficiency-and-cost-effectiveness-of-artificial-intelligence-based-diabetic-retinopathy-screening-in-flanders-15196https://curecurrent.com/trials/prevalence-and-factors-associated-with-pancreatic-enzyme-elevations-among-diabetic-children-15197https://curecurrent.com/trials/urica-cor-intervention-uricori-trial-15198https://curecurrent.com/trials/effect-of-deferoxamine-on-wound-healing-rate-in-patients-with-diabetes-foot-ulcers-15199https://curecurrent.com/trials/prevention-of-maternal-and-fetal-metabolic-complications-with-diet-and-nutraceutical-supplementation-in-pregnant-women-a-15200https://curecurrent.com/trials/desferal-administration-to-improve-the-impaired-reaction-to-hypoxia-in-diabetes-15201https://curecurrent.com/trials/repeatability-of-static-dynamic-composite-confocal-microscopy-for-assessment-of-the-corneal-nerve-fiber-plexus-in-early-15202https://curecurrent.com/trials/copeptin-after-a-subcutaneous-stimulation-with-glucagon-in-adults-15203https://curecurrent.com/trials/association-between-time-in-range-and-in-hospital-outcomes-in-type-2-diabetic-patients-with-acute-coronary-syndrome-15204https://curecurrent.com/trials/association-of-long-term-conditions-with-survival-following-heart-attack-in-england-and-wales-15205https://curecurrent.com/trials/use-of-nutraceuticals-in-clinical-practice-15206https://curecurrent.com/trials/use-of-incretins-in-diabetic-patients-15207https://curecurrent.com/trials/effects-of-a-workplace-exercise-intervention-on-cardio-metabolic-health-15208https://curecurrent.com/trials/aralast-np-in-islet-transplant-15209https://curecurrent.com/trials/continuous-glucose-monitoring-and-inflammation-in-nondiabetic-and-diabetic-patients-undergone-hemodialysis-15210https://curecurrent.com/trials/semaglutide-anti-atherosclerotic-mechanisms-of-action-study-in-type-2-diabetes-patients-15211https://curecurrent.com/trials/impact-of-bilingual-prescription-medication-labels-among-elderly-singaporeans-15212https://curecurrent.com/trials/circadian-high-intensity-interval-training-study-15213https://curecurrent.com/trials/a-first-trimester-prediction-model-for-large-for-gestational-age-infants-a-preliminary-study-15214https://curecurrent.com/trials/diabetes-and-psoriasis-15215https://curecurrent.com/trials/adherence-to-activity-limitations-in-diabetes-15216https://curecurrent.com/trials/atherosclerotic-cardiovascular-risk-in-childhood-and-teen-age-onset-diabetes-15217https://curecurrent.com/trials/a-pilot-trial-of-the-non-invasive-h-g-r-glucometer-15218https://curecurrent.com/trials/phacoemulsification-combined-with-intravitreal-injection-of-ranibizumab-prevent-postoperative-capillary-non-perfusion-zo-15219https://curecurrent.com/trials/interest-of-smartguard-technology-predictive-system-for-stopping-insulin-before-hypoglycemia-in-children-with-type-1-dia-15220https://curecurrent.com/trials/early-high-dose-vitamin-d-and-residual-cell-function-in-pediatric-type-1-diabetes-15221https://curecurrent.com/trials/the-effect-of-glimepiride-compared-with-sitagliptin-as-an-add-on-therapy-to-metformin-in-severe-insulin-deficiency-diabe-15222https://curecurrent.com/trials/diabetic-foot-self-care-15223https://curecurrent.com/trials/macrophage-phenotype-in-type-2-diabetics-after-myocardial-infarction-and-the-potential-role-of-mirnas-secreted-15224https://curecurrent.com/trials/telepharmaceutical-care-diabetes-trial-15225https://curecurrent.com/trials/diabetes-type-2-in-the-eastern-region-of-morocco-15226https://curecurrent.com/trials/telmisartan-promotes-the-differentiation-of-monocytes-into-macrophages-m2-in-diabetic-nephropathy-15227https://curecurrent.com/trials/relaxation-intervention-in-patients-with-diabetic-foot-ulcer-15228https://curecurrent.com/trials/educational-interventions-on-diabetic-foot-care-15229https://curecurrent.com/trials/a-drug-interaction-study-of-sy-004-capsules-in-healthy-subjects-15230https://curecurrent.com/trials/behavioural-economics-based-incentives-in-adults-with-type-2-diabetes-pilot-study-15231https://curecurrent.com/trials/dapagliflozin-during-exercise-for-the-prevention-of-hypoglycaemia-15232https://curecurrent.com/trials/external-shoe-lift-to-improve-healing-and-adherence-in-patients-with-diabetic-foot-ulcers-15233https://curecurrent.com/trials/time-restricted-feeding-to-reduce-weight-and-cardiometabolic-risk-15234https://curecurrent.com/trials/perception-of-blood-sugar-variations-during-physical-activity-in-healthy-subjects-and-type-1-diabetes-patients-15235https://curecurrent.com/trials/investigating-plasma-biomarker-molecules-associated-with-the-progression-of-prediabetes-to-overt-type-2-diabetes-15236https://curecurrent.com/trials/exercise-intervention-for-the-prevention-of-prediabetes-in-overweight-chinese-15237https://curecurrent.com/trials/the-effect-of-blood-flow-restriction-training-on-glycemic-control-among-type-2-diabetes-patients-15238https://curecurrent.com/trials/physical-activity-and-mortality-in-type-2-diabetes-15239https://curecurrent.com/trials/a-food-drug-interaction-study-of-sy-004-in-healthy-subjects-15240https://curecurrent.com/trials/improving-individual-glycemic-response-with-exercise-intensity-15241https://curecurrent.com/trials/effects-of-replacing-red-meat-with-legumes-on-biomarkers-of-chronic-diseases-in-healthy-men-leg4life-15242https://curecurrent.com/trials/multiple-ascending-doses-of-sy-008-in-type-2-diabetes-mellitus-15243https://curecurrent.com/trials/the-efficacy-and-safety-of-different-doses-of-sy-004-in-patients-with-type-2-diabetes-mellitus-15244https://curecurrent.com/trials/translating-genetic-knowledge-into-clinical-care-in-non-autoimmune-diabetes-15245https://curecurrent.com/trials/postprandial-metabolism-after-bariatric-surgery-in-type-2-diabetes-15246https://curecurrent.com/trials/the-effect-of-the-spiritual-diary-in-children-15247https://curecurrent.com/trials/eye-tracking-based-artificial-intelligence-detects-abnormalities-of-the-oculomotor-system-in-type-1-diabetes-15248https://curecurrent.com/trials/closed-loop-in-adults-with-t2d-requiring-dialysis-15249https://curecurrent.com/trials/quantitative-assessment-and-characterization-of-microvascular-function-using-diffuse-optical-tomography-15250https://curecurrent.com/trials/performance-and-patient-acceptance-of-a-commercially-available-beverage-as-compared-to-an-oral-glucose-solution-for-oral-15251https://curecurrent.com/trials/safety-and-efficacy-of-duo-extended-set-combined-glucose-sensor-and-infusion-set-15252https://curecurrent.com/trials/psychosocial-factors-affecting-glycemic-control-in-children-and-adolescents-with-type-1-diabetes-mellitus-15253https://curecurrent.com/trials/effect-of-a-very-low-calorie-ketogenic-diet-on-gut-microbiota-and-fat-distribution-15254https://curecurrent.com/trials/effects-of-high-intensity-interval-training-and-combined-training-in-type-2-diabetic-t2d-patients-15255https://curecurrent.com/trials/adapting-the-diabetes-prevention-program-for-a-developing-world-context-15256https://curecurrent.com/trials/comparison-between-the-efficacy-of-sglt2-inhibitor-therapy-versus-ace-inhibitor-in-the-treatment-of-diabetic-kidney-dise-15257https://curecurrent.com/trials/type-2-diabetes-prevention-toolkit-for-health-care-professionals-15258https://curecurrent.com/trials/dose-finding-study-of-colchicine-in-type-2-diabetic-patients-with-coronary-artery-disease-15259https://curecurrent.com/trials/efficacy-of-the-digital-platform-for-diabetes-care-compared-to-usual-care-in-patients-diagnosed-with-type-2-diabetes-15260https://curecurrent.com/trials/meal-handling-of-advanced-closed-loop-insulin-delivery-15261https://curecurrent.com/trials/cooking-and-nutrition-education-for-health-among-adults-with-diabetes-15262https://curecurrent.com/trials/islet-isolation-using-mnte-2-pyp-bmx-010-pilot-study-15263https://curecurrent.com/trials/the-curative-effect-of-the-length-of-the-jejunum-exclusion-in-grstric-bypass-surgery-for-type-2-diabetes-15264https://curecurrent.com/trials/safety-tolerance-and-pharmacokinetics-of-thr-1442-in-chinese-healthy-subjects-15265https://curecurrent.com/trials/plasma-transthyretin-levels-and-risk-of-type-2-diabetes-mellitus-and-impaired-glucose-regulation-15266https://curecurrent.com/trials/investigation-of-milk-peptides-pep2dia-on-postprandial-blood-glucose-profile-in-prediabetic-subjects-15267https://curecurrent.com/trials/a-phase-i-ii-study-of-the-safety-and-efficacy-of-sernova-s-cell-pouchtm-for-therapeutic-islet-transplantation-15268https://curecurrent.com/trials/nocardia-cell-wall-skeleton-for-the-treatment-of-diabetic-foot-ulcer-wounds-15269https://curecurrent.com/trials/the-effect-of-meal-replacement-on-the-time-to-reach-the-blood-glucose-target-in-patients-with-type-2-diabetes-mellitus-15270https://curecurrent.com/trials/omental-islet-transplant-15271https://curecurrent.com/trials/development-of-continuous-glucose-monitoring-system-cohort-for-personalized-diabetes-prevention-and-management-platform-15272https://curecurrent.com/trials/early-laser-treatment-for-diabetic-eye-disease-in-china-a-pilot-randomized-trial-15273https://curecurrent.com/trials/effects-of-caloric-restriction-in-obesity-and-type-2-diabetes-15274https://curecurrent.com/trials/rajavithi-health-promotion-project-population-base-cohort-15275https://curecurrent.com/trials/coronary-artery-calcium-guided-primary-prevention-of-major-coronary-heart-disease-in-asymptomatic-diabetes-15276https://curecurrent.com/trials/probiotics-in-metformin-intolerant-patients-with-type-2-diabetes-15277https://curecurrent.com/trials/place-of-glycation-in-diabetic-retinopathy-15278https://curecurrent.com/trials/acute-studies-on-the-glycemic-index-after-intake-of-different-sorts-of-barley-in-subjects-with-type-2-diabetes-15279https://curecurrent.com/trials/cardiac-autonomic-dysfunction-in-diabetics-patients-with-syncope-15280https://curecurrent.com/trials/placebo-controlled-clinical-nutrition-study-of-the-metabolic-effects-of-food-product-wbf-0011-in-type-2-diabetes-15281https://curecurrent.com/trials/role-of-fexofenadine-in-diabetic-kidney-disease-15282https://curecurrent.com/trials/10-years-follow-up-study-of-plantar-pressure-kinetics-and-kinematics-in-a-cohort-of-patients-diagnosed-with-diabetes-15283https://curecurrent.com/trials/the-headwind-study-part-3-15284https://curecurrent.com/trials/implementation-of-the-d-foot-at-the-department-of-prosthetics-and-orthotics-15285https://curecurrent.com/trials/type-1-diabetes-and-depression-role-of-brain-glutamate-15286https://curecurrent.com/trials/monitoring-parameters-beyond-glycemic-control-impact-of-sitagliptin-on-quality-of-life-in-type-2-diabetes-patients-15287https://curecurrent.com/trials/clinical-characteristics-of-people-with-long-term-type-1-diabetes-15288https://curecurrent.com/trials/liraglutide-improve-cognitive-function-in-patients-with-type-2-diabetes-mellitus-15289https://curecurrent.com/trials/which-is-better-to-start-with-dpp-4-inhibitors-or-sglt-2-inhibitors-in-egyptian-diabetic-patients-15290https://curecurrent.com/trials/comparison-of-empaglifozin-and-vildagliptin-in-type-2-diabetes-mellitus-15291https://curecurrent.com/trials/comparison-of-ocular-surface-features-in-patients-with-diabetes-and-dry-eye-syndrome-15292https://curecurrent.com/trials/investigate-the-efficacy-and-safety-of-low-glu-in-patients-newly-diagnosed-with-type-ii-diabetes-mellitus-15293https://curecurrent.com/trials/open-label-single-arm-proof-of-concept-trial-to-evaluate-the-efficacy-and-safety-of-cytori-celution-system-in-diabetic-l-15294https://curecurrent.com/trials/comparison-of-retinal-perfusion-between-diabetic-and-non-diabetic-patients-with-oct-angiography-after-cataract-surgery-15295https://curecurrent.com/trials/effect-of-lifestyle-modification-on-pregnancy-outcome-for-gdm-15296https://curecurrent.com/trials/nafld-among-patients-with-chronic-kidney-disease-and-the-effect-of-kidney-transplantation-15297https://curecurrent.com/trials/imcy-t1d-002-long-term-follow-up-study-of-t1d-patients-previously-treated-with-imcy-0098-or-placebo-15298https://curecurrent.com/trials/epigenetic-contribution-to-the-pathogenesis-of-diabetic-nephropathy-in-qatari-population-15299https://curecurrent.com/trials/teaching-method-with-simulation-in-gestational-diabetes-mellitus-management-15300https://curecurrent.com/trials/modified-diabetes-prevention-program-in-ecuador-15301https://curecurrent.com/trials/implementation-of-a-comprehensive-intervention-on-hypertension-htn-and-type-2-diabetes-mellitus-dm-at-phc-level-15302https://curecurrent.com/trials/a-trial-investigating-the-effect-of-4-weeks-dosing-of-xen-d0501-on-blood-glucose-reduction-in-patients-with-diabetes-15303https://curecurrent.com/trials/nephrologic-prognosis-10-years-after-diabetes-cell-therapy-15304https://curecurrent.com/trials/laser-therapy-for-at-home-treatment-of-diabetic-foot-ulcers-lll-diab-03-15305https://curecurrent.com/trials/effects-of-plant-based-lipids-on-glucose-regulation-and-cognitive-variables-15306https://curecurrent.com/trials/post-aca-reform-evaluation-of-community-health-center-care-of-diabetes-15307https://curecurrent.com/trials/primary-care-based-integrated-community-care-team-intervention-15308https://curecurrent.com/trials/overview-of-telemedicine-in-children-with-type-1-diabetes-15309https://curecurrent.com/trials/tele-expertise-in-patients-with-diabetes-hospitalized-for-covid-19-infection-15310https://curecurrent.com/trials/pathways-for-health-equity-quality-improvement-strategy-15311https://curecurrent.com/trials/health-indicators-and-patient-reported-outcomes-identification-of-significative-items-aimed-at-improving-health-care-pro-15312https://curecurrent.com/trials/guided-user-initiated-insulin-dose-enhancements-guide-to-improve-outcomes-for-youth-with-type-1-diabetes-15313https://curecurrent.com/trials/nasturtium-tropaeolum-majus-l-intake-and-biochemical-parameters-in-pre-diabetic-subjects-in-bogota-colombia-15314https://curecurrent.com/trials/monocyte-soluble-activation-markers-scd14-and-scd163-in-children-with-type-1-diabetes-mellitus-15315https://curecurrent.com/trials/patient-activation-through-community-empowerment-engagement-for-diabetes-management-pace-d-15316https://curecurrent.com/trials/association-of-type-1-diabetes-mellitus-in-offsprings-with-positive-parental-history-of-diabetes-15317https://curecurrent.com/trials/assessment-study-of-three-different-fasting-plasma-glucose-targets-in-chinese-patients-with-type-2-diabetes-mellitus-bey-15318https://curecurrent.com/trials/efficacy-and-safety-of-the-insulin-glargine-lixisenatide-fixed-ratio-combination-versus-insulin-glargine-in-patients-wit-15319https://curecurrent.com/trials/personalised-exercise-training-in-adolescents-with-type-2-diabetes-for-the-early-prevention-of-beta-cell-dysfunction-15320https://curecurrent.com/trials/sotagliflozin-multiple-dose-study-in-healthy-chinese-subjects-15321https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-vs-acarbose-in-chinese-type-2-diabetes-mellitus-t2dm-patients-with-high-cv-risk-or-chd-15322https://curecurrent.com/trials/effect-of-rifampicin-on-the-pharmacokinetics-and-pharmacodynamics-of-sotagliflozin-15323https://curecurrent.com/trials/safety-assessment-of-lyxumia-lixisenatide-and-sulfonylurea-as-add-on-treatment-to-basal-insulin-in-uncontrolled-patients-15324https://curecurrent.com/trials/a-real-world-trial-to-determine-efficacy-and-health-outcomes-of-toujeo-compared-to-standard-of-care-basal-insulin-in-pat-15325https://curecurrent.com/trials/comparison-of-standard-vs-higher-starting-dose-of-insulin-glargine-in-chinese-patients-with-type-2-diabetes-glargine-sta-15326https://curecurrent.com/trials/comparison-of-pharmacodynamic-effects-of-sotagliflozin-and-empagliflozin-in-t2dm-patients-with-mild-to-moderate-hyperten-15327https://curecurrent.com/trials/twelve-month-study-observing-how-insulin-na-ve-patients-with-type-2-diabetes-mellitus-manage-diabetes-using-toujeo-after-15328https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-insulin-glargine-300-u-ml-in-patients-with-type-2-diabetes-mellitus-uncontrolle-15329https://curecurrent.com/trials/comparison-of-two-treatment-regimens-in-patients-with-type-2-diabetes-after-short-term-intensive-insulin-therapy-15330https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-a-new-formulation-of-insulin-glargine-with-lantus-in-patients-with-type-2-diabe-15331https://curecurrent.com/trials/a-real-world-trial-to-determine-efficacy-and-health-outcomes-of-toujeo-compared-to-standard-of-care-basal-insulins-in-in-15332https://curecurrent.com/trials/study-to-determine-bioavailability-of-sotagliflozin-in-healthy-male-and-female-subjects-15333https://curecurrent.com/trials/a-clinical-study-to-investigate-if-sar425899-binds-to-the-liver-and-pancreas-in-overweight-to-obese-type-2-diabetes-mell-15334https://curecurrent.com/trials/pharmacodynamic-study-to-assess-the-effects-of-repeated-dosing-of-sar247799-on-endothelial-function-in-patients-with-typ-15335https://curecurrent.com/trials/evaluation-of-toujeo-insulin-in-type-2-diabetes-patients-inadequately-control-with-their-basal-insulin-treatment-15336https://curecurrent.com/trials/phase-4-study-to-evaluate-treatment-optimization-with-once-daily-insulin-glargine-300-u-ml-15337https://curecurrent.com/trials/a-study-to-demonstrate-bioequivalence-between-insulin-glulisine-u300-and-insulin-glulisine-u100-after-a-single-subcutane-15338https://curecurrent.com/trials/interaction-study-to-evaluate-the-effects-of-mefenamic-acid-on-the-pharmacokinetics-and-pharmacodynamics-of-sotagliflozi-15339https://curecurrent.com/trials/comparison-of-exposure-and-activity-of-sar341402-mix-70-30-to-novolog-mix-70-30-novomix-30-and-sar341402-rapid-acting-so-15340https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-placebo-in-chinese-patients-with-type-2-diabetes-mellitus-not-adequately-con-15341https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-placebo-in-chinese-patients-with-type-2-diabetes-mellitus-not-adequately-con-15342https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-food-on-the-pharmacokinetics-of-sotagliflozin-and-to-explore-the-relative-bioavailabil-15343https://curecurrent.com/trials/study-comparing-the-efficacy-and-safety-of-insulin-glargine-basal-insulin-lixisenatide-glp-1-receptor-agonist-combinatio-15344https://curecurrent.com/trials/a-study-to-compare-pharmacokinetics-pk-and-pharmacodynamics-pd-of-sar341402-to-insulin-aspart-in-subjects-with-type-1-di-15345https://curecurrent.com/trials/evaluating-dynamic-myocardial-blood-flow-quantitation-as-a-cost-effective-care-model-for-diabetic-patients-with-coronary-15346https://curecurrent.com/trials/a-drug-drug-interaction-study-between-sotagliflozin-and-ramipril-15347https://curecurrent.com/trials/azd1656-in-diabetic-patients-hospitalised-with-suspected-or-confirmed-covid-19-15348https://curecurrent.com/trials/new-diagnosed-type-2-diabetes-online-education-15349https://curecurrent.com/trials/the-effect-of-sglt2-inhibitors-on-cognitive-functions-and-bdnf-levels-in-patients-with-type-2-diabetes-15350https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-pb-201-in-type-2-diabetic-mellitus-patients-with-poor-glycemic-control-via-15351https://curecurrent.com/trials/the-wellness-transformation-network-pilot-study-15352https://curecurrent.com/trials/coronary-artery-disease-progression-in-patients-with-prediabetes-15353https://curecurrent.com/trials/management-of-the-diabetic-foot-using-electrolysed-water-15354https://curecurrent.com/trials/evaluation-of-an-early-screener-to-identify-long-term-problems-with-regard-to-metabolic-control-and-treatment-adherence-15355https://curecurrent.com/trials/survey-of-patient-and-physician-awareness-and-values-to-the-diagnosis-and-treatment-of-reduced-kidney-function-chronic-k-15356https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-multicenter-clinical-trial-to-evaluate-the-clinical-efficacy-and-safety-of-15357https://curecurrent.com/trials/changes-of-serum-orphanin-fq-in-patients-with-coronary-heart-disease-in-different-courses-of-diabetes-mellitus-15358https://curecurrent.com/trials/indocyanine-green-test-for-evaluation-of-perfusion-of-staple-line-of-the-stomach-during-laparoscopic-sleeve-gastrectomy-15359https://curecurrent.com/trials/foot-care-assessment-and-relation-to-diabetic-complications-15360https://curecurrent.com/trials/evaluation-of-the-ottawa-model-for-smoking-cessation-in-diabetes-education-programs-15361https://curecurrent.com/trials/painless-myocardial-ischemia-in-diabetic-patients-15362https://curecurrent.com/trials/roy-adaptation-model-in-people-with-type-1-diabetes-15363https://curecurrent.com/trials/integration-of-health-coaching-and-diabetes-education-in-type-2-diabetes-mellitus-management-at-primary-health-care-15364https://curecurrent.com/trials/using-a-diabetic-kidney-disease-dkd-registry-to-treat-to-multiple-targets-tmt-15365https://curecurrent.com/trials/comparing-the-effect-of-structured-care-versus-usual-care-in-type-2-diabetes-patients-across-the-asia-pacific-region-15366https://curecurrent.com/trials/characterization-of-type-2-diabetes-subgroups-at-diagnosis-a-necessary-step-towards-precision-medicine-in-diabetes-15367https://curecurrent.com/trials/gut-microbiota-in-chronic-noncommunicable-diseases-15368https://curecurrent.com/trials/covid-19-aging-and-cardiometabolic-risk-factors-study-15369https://curecurrent.com/trials/the-efficacy-of-sglt-2-inhibitor-in-patients-with-cad-and-dm-undergoing-pci-15370https://curecurrent.com/trials/study-on-the-population-pharmacokinetics-of-levetiracetam-in-epileptic-patients-with-diabetic-kidney-disease-15371https://curecurrent.com/trials/effects-of-combined-dapagliflozin-and-exenatide-versus-dapagliflozin-and-placebo-on-ectopic-lipids-in-patients-with-unco-15372https://curecurrent.com/trials/difference-of-basal-insulin-titration-method-in-reducing-hba1c-among-type-2-diabetes-mellitus-t2dm-patients-15373https://curecurrent.com/trials/the-effect-of-family-support-on-diabetes-patients-health-beliefs-behavioral-and-metabolic-results-15374https://curecurrent.com/trials/the-study-aims-to-show-bioequivalence-of-the-test-product-and-the-reference-reference-product-in-a-crossover-design-stud-15375https://curecurrent.com/trials/caspase-inhibition-in-islet-transplantation-15376https://curecurrent.com/trials/accelerated-rule-out-of-myocardial-infarction-15377https://curecurrent.com/trials/food-collection-from-type-1-diabetic-patients-practicing-insulin-functional-therapy-15378https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-compared-to-dulaglutide-in-participants-with-type-2-diabetes-15379https://curecurrent.com/trials/human-milk-understanding-the-mechanisms-linked-to-the-prevention-of-obesity-and-diabetes-in-children-exposed-in-utero-to-15380https://curecurrent.com/trials/lipoprotein-associated-phospholipase-a2-in-patients-with-type-2-diabetes-15381https://curecurrent.com/trials/circulating-oxytocin-changes-in-response-to-the-oxytocin-system-stimulator-mdma-in-patients-with-diabetes-insipidus-and-15382https://curecurrent.com/trials/assessment-of-personalized-follow-up-in-prevention-of-type-2-diabetes-15383https://curecurrent.com/trials/assessment-of-the-safety-and-effect-of-sar425899-versus-placebo-for-the-treatment-of-non-alcoholic-fatty-liver-disease-15384https://curecurrent.com/trials/evaluation-of-the-fixed-dose-combination-of-irbesartan-atorvastatin-in-type-2-diabetic-patients-diagnosed-with-hyperlipi-15385https://curecurrent.com/trials/comparison-of-sotagliflozin-prototype-tablets-with-reference-tablet-in-healthy-subjects-15386https://curecurrent.com/trials/analysis-of-influencing-factors-of-hypotension-in-diabetic-patients-undergoing-dialysis-15387https://curecurrent.com/trials/dual-wavelength-oct-15388https://curecurrent.com/trials/the-effect-of-liraglutide-treatment-on-postprandial-chylomicron-and-vldl-kinetics-liver-fat-and-de-novo-lipogenesis-15389https://curecurrent.com/trials/cstc1-for-diabetic-foot-ulcers-phase-ii-study-15390https://curecurrent.com/trials/metformin-in-diabetic-patients-undergoing-coronary-angiography-15391https://curecurrent.com/trials/encapsulated-faecal-microbiota-transplantation-to-preserve-residual-beta-cell-function-in-type-1-diabetes-mellitus-15392https://curecurrent.com/trials/data-acquisition-study-in-inadequately-balanced-patients-with-type-2-diabetes-mellitus-15393https://curecurrent.com/trials/preserving-beta-cell-function-in-type-2-diabetes-with-exenatide-and-insulin-prevail-15394https://curecurrent.com/trials/atrial-fibrillation-research-in-catalonia-15395https://curecurrent.com/trials/sahoor-meal-regimen-for-patients-with-type1-diabetes-15396https://curecurrent.com/trials/relationship-between-gestational-diabetes-and-type-2-diabetes-15397https://curecurrent.com/trials/egg-yolk-and-underlying-metabolisms-on-modifying-hdl-levels-in-individuals-with-metabolic-syndrome-15398https://curecurrent.com/trials/towards-a-better-understanding-of-diabetes-distress-depression-and-poor-glycaemic-control-in-t2dm-15399https://curecurrent.com/trials/eating-disorders-in-type-1-insulin-dependent-diabetes-patients-15400https://curecurrent.com/trials/impact-of-high-protein-and-low-carbohydrate-smoothie-drinks-in-type-2-diabetes-mellitus-15401https://curecurrent.com/trials/feasibility-of-a-postpartum-lifestyle-intervention-on-the-cardiometabolic-risk-profile-of-gdm-women-15402https://curecurrent.com/trials/prevalence-of-musculoskeletal-disorders-of-upper-limb-in-type-1-diabetes-patients-15403https://curecurrent.com/trials/role-of-lncrna-h19-in-the-regulation-of-igf-1r-expression-15404https://curecurrent.com/trials/clinical-feasibility-and-efficacy-of-intermittent-use-of-a-fasting-mimicking-diet-in-the-treatment-of-type-2-diabetes-15405https://curecurrent.com/trials/a-complex-health-promotion-intervention-in-parasport-the-safe-healthy-parasport-project-15406https://curecurrent.com/trials/effect-of-fiasp-in-type-1-diabetes-treatment-15407https://curecurrent.com/trials/the-effects-of-calcitriol-on-biomarkers-in-diabetic-kidney-disease-patients-15408https://curecurrent.com/trials/elucidating-the-mechanism-of-remission-of-type-2-diabetes-in-morbid-obese-patients-after-bariatric-surgery-15409https://curecurrent.com/trials/comparing-the-compliance-to-follow-up-in-patients-with-diabetic-macular-edema-15410https://curecurrent.com/trials/diabetic-neuropathy-rapid-screening-test-in-turkish-patients-with-type-2-diabetes-sudoscan-15411https://curecurrent.com/trials/botulinum-toxin-type-a-in-diabetic-peripheral-neuropathy-15412https://curecurrent.com/trials/a-study-for-post-marketing-surveillance-of-nesina-tablet-monotherapy-or-combination-therapy-in-participants-with-type-2-15413https://curecurrent.com/trials/towards-home-based-albuminuria-screening-an-implementation-study-testing-two-approaches-15414https://curecurrent.com/trials/the-possible-effects-of-roflumilast-on-obesity-related-disorders-15415https://curecurrent.com/trials/a-single-dose-and-multiple-dose-study-to-evaluate-the-pharmacokinetics-and-pharmacodynamics-of-dbpr108-tablets-in-type-2-15416https://curecurrent.com/trials/effects-of-gelesis200-on-appetite-parameters-food-intake-and-glycemic-control-in-overweight-or-obese-prediabetic-subject-15417https://curecurrent.com/trials/system-accuracy-of-a-blood-glucose-monitoring-system-glucospark-glucoscore-15418https://curecurrent.com/trials/network-meta-analysis-of-intermittent-fasting-and-cardiometabolic-risk-15419https://curecurrent.com/trials/diabetic-retinopathy-as-a-marker-of-cognitive-dysfunction-and-depression-15420https://curecurrent.com/trials/mobile-health-intervention-for-improved-adherence-in-type-2-diabetes-15421https://curecurrent.com/trials/statins-in-patients-with-type-2-diabetes-mellitus-and-previous-history-of-acute-coronary-syndrome-15422https://curecurrent.com/trials/combined-antioxidant-therapy-on-oxidative-stress-mitochondrial-dysfunction-markers-in-diabetic-retinopathy-15423https://curecurrent.com/trials/decline-in-renal-concentration-ability-in-lithium-treated-patients-15424https://curecurrent.com/trials/combined-antioxidant-therapy-on-oxidative-stress-in-aqueous-and-vitreous-humor-of-diabetic-retinopathy-patients-15425https://curecurrent.com/trials/the-efficacy-nad-safety-of-dwp16001-compared-to-active-drug-in-the-treatment-of-type-2-diabetes-mellitus-15426https://curecurrent.com/trials/multiple-ascending-doses-of-sy-009-in-type-2-diabetes-mellitus-15427https://curecurrent.com/trials/antenatal-hand-milking-for-pregnant-women-with-diabetes-15428https://curecurrent.com/trials/the-impact-of-glycemic-index-education-on-lowering-dietary-gi-in-gestational-diabetes-mellitus-15429https://curecurrent.com/trials/correlation-study-between-clinical-phenotype-and-pathology-of-type-2-diabetic-nephropathy-15430https://curecurrent.com/trials/all-encompassing-program-led-by-diabetes-specialist-team-15431https://curecurrent.com/trials/adherence-and-beliefs-about-medications-and-illness-perception-among-type-2-diabetic-patients-in-assiut-main-hospital-15432https://curecurrent.com/trials/semaglutide-as-an-adjunct-to-dieting-in-the-treatment-of-type-2-diabetes-15433https://curecurrent.com/trials/telocytes-in-placental-tissues-of-patients-with-gestational-and-pre-gestational-diabetes-15434https://curecurrent.com/trials/efficacy-and-safety-study-of-a-low-carbohydrate-tube-feed-in-critically-ill-patients-under-insulin-therapy-15435https://curecurrent.com/trials/the-outcomes-of-intracavernosal-umbilical-cord-mesenchymal-stem-cells-implantation-in-patients-with-diabetic-erectile-dy-15436https://curecurrent.com/trials/adipose-tissue-pre-and-post-bariatric-surgery-15437https://curecurrent.com/trials/development-of-an-information-board-and-mobile-application-for-the-care-of-type-2-diabetes-15438https://curecurrent.com/trials/effect-of-dulaglutide-on-glycemic-variability-in-patients-with-type-2-diabetes-15439https://curecurrent.com/trials/participatory-patient-care-planning-in-primary-care-15440https://curecurrent.com/trials/the-effect-of-circuit-exercise-program-in-gestational-diabetes-15441https://curecurrent.com/trials/the-salivary-microbiome-in-children-with-type-1-diabetes-mellitus-15442https://curecurrent.com/trials/type-2-diabetes-glucose-biomarker-study-with-a-continuous-glucose-monitoring-system-15443https://curecurrent.com/trials/use-of-ozonized-water-with-toothpaste-and-mousse-in-non-surgical-periodontal-therapy-for-patients-with-diabetes-mellitus-15444https://curecurrent.com/trials/berberine-prevent-contrast-induced-nephropathy-in-patients-with-diabetes-15445https://curecurrent.com/trials/glp-analogs-for-diabetes-in-wolfram-syndrome-patients-15446https://curecurrent.com/trials/flexor-tenotomy-and-ulcer-recurrence-15447https://curecurrent.com/trials/pancreatic-calcium-handling-in-islet-beta-cells-in-patients-with-type-1-diabetes-mellitus-15448https://curecurrent.com/trials/prevention-of-gestational-diabetes-15449https://curecurrent.com/trials/modification-of-gut-microbiota-in-the-treatment-of-insulin-resistance-a-personalized-approach-15450https://curecurrent.com/trials/aronia-in-the-type-2-diabetes-treatment-regimen-15451https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-jt-003-add-on-in-patients-with-type-2-diabetes-mellitus-inadequately-controlled-w-15452https://curecurrent.com/trials/randomized-clinical-trial-medical-vs-bariatric-surgery-for-adolescents-13-16-y-with-severe-obesity-15453https://curecurrent.com/trials/effect-of-compound-danshen-dripping-pills-on-diabetic-patients-with-coronary-microcirculation-disturbance-15454https://curecurrent.com/trials/remission-evaluation-of-a-metabolic-intervention-in-type-2-diabetes-with-sitagliptin-remit-sita-15455https://curecurrent.com/trials/metformin-usage-index-and-vitamin-b12-status-in-egyptian-type-2-diabetic-patients-15456https://curecurrent.com/trials/1-5-anhydroglucitol-and-1-5-anhydroglucitol-glycated-hemoglobin-ratio-as-a-potential-biomarker-for-islet-cell-function-a-15457https://curecurrent.com/trials/a-pharmacokinetic-study-comparing-the-liraglutide-injection-rd12014-and-victoza-in-healthy-chinese-subjects-15458https://curecurrent.com/trials/effect-of-milk-consumption-on-glycemia-and-gut-microbiome-in-t2d-15459https://curecurrent.com/trials/autologous-regenerative-islet-transplantation-for-insulin-dependent-diabetes-15460https://curecurrent.com/trials/understanding-grocery-shopping-behaviour-15461https://curecurrent.com/trials/np-supported-multidisciplinary-diabetes-management-during-perioperative-period-15462https://curecurrent.com/trials/are-diabetics-type-2-more-prone-to-dental-caries-15463https://curecurrent.com/trials/biomarkers-of-heterogeneity-in-type-1-diabetes-15464https://curecurrent.com/trials/optimising-health-in-type-1-diabetes-15465https://curecurrent.com/trials/tangningtongluo-tablet-for-people-with-prediabetes-15466https://curecurrent.com/trials/investigation-of-chronotropic-index-exercise-capacity-in-type-1-diabetes-mellitus-15467https://curecurrent.com/trials/ypsopump-occlusion-detection-algorithm-collection-of-real-world-data-for-in-silico-evaluation-of-a-new-software-algorith-15468https://curecurrent.com/trials/linagliptin-response-to-ogtt-in-prediabetes-and-type-2-diabetes-mellitus-15469https://curecurrent.com/trials/efficacy-and-safety-of-dapagliflozin-when-added-to-ongoing-metformin-and-evogliptin-combination-therapy-in-patients-with-15470https://curecurrent.com/trials/adipose-tissue-dysfunction-in-type-2-diabetes-and-its-reversibility-by-bariatric-surgery-15471https://curecurrent.com/trials/audit-and-feedback-for-general-practitioners-in-the-intego-network-15472https://curecurrent.com/trials/a-prospective-cohort-study-forecast-fracture-risk-with-a-serum-marker-of-type-2-diabetes-in-guangzhou-community-15473https://curecurrent.com/trials/genetic-testing-and-counseling-to-reduce-diabetic-complications-15474https://curecurrent.com/trials/effect-of-oral-anti-diabetic-medication-on-liver-fat-in-subjects-with-type-ii-diabetes-and-non-alcoholic-fatty-liver-15475https://curecurrent.com/trials/validation-of-a-13c-glucose-breath-test-compared-with-the-euglycaemic-clamp-test-15476https://curecurrent.com/trials/social-media-delivered-patient-education-in-enhancing-type-2-diabetics-self-management-and-attitudes-during-the-covid-19-15477https://curecurrent.com/trials/a-clinical-intervention-study-of-tangningtongluo-on-diabetic-foot-ulcer-15478https://curecurrent.com/trials/effect-of-time-restricted-eating-on-behaviour-and-metabolism-in-overweight-individuals-at-high-risk-of-type-2-diabetes-15479https://curecurrent.com/trials/associations-of-plasma-vanadium-concentrations-with-gestational-diabetes-mellitus-15480https://curecurrent.com/trials/observational-study-gemigliptin-in-patients-aged-65-years-with-type-2-diabetes-mellitus-15481https://curecurrent.com/trials/evaluation-and-intervention-of-cognitive-function-in-patients-with-diabetes-mellitus-15482https://curecurrent.com/trials/hybridized-three-steps-intervention-to-prevent-diabetes-in-venezuela-15483https://curecurrent.com/trials/effect-of-rygb-on-alpha-and-beta-cell-function-and-sensitivity-to-incretins-in-patients-with-type-2-diabetes-15484https://curecurrent.com/trials/effectiveness-of-diabetes-prevention-education-program-on-diabetes-prevention-among-prediabetes-population-in-nepal-15485https://curecurrent.com/trials/lifestyle-modification-to-improve-diet-in-women-with-gdm-15486https://curecurrent.com/trials/glucagon-like-peptide-1-levels-insulin-resistance-and-insulin-sensitivity-index-in-type-2-diabetes-mellitus-15487https://curecurrent.com/trials/effect-of-low-level-laser-therapy-on-type-ii-controlled-diabetic-patients-after-dental-implant-insertion-15488https://curecurrent.com/trials/the-effect-of-shr20004-noiiglutide-on-body-weight-in-obese-subjects-without-diabetes-15489https://curecurrent.com/trials/dulaglutide-versus-liraglutide-in-obese-type-2-diabetic-adolescents-using-metformin-15490https://curecurrent.com/trials/codiab-vd-a-population-based-cohort-on-quality-of-care-of-patients-with-diabetes-in-the-canton-of-vaud-switzerland-15491https://curecurrent.com/trials/the-effects-of-glycemic-optimization-before-gastric-bypass-surgery-15492https://curecurrent.com/trials/effects-of-12-weeks-of-quantitative-weight-bearing-progressive-resistance-exercise-training-on-glycemia-control-and-impr-15493https://curecurrent.com/trials/the-effect-of-sensorial-biodex-balance-balance-system-exercises-in-diabetic-neuropathy-15494https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pf-06882961-in-japanese-adults-with-15495https://curecurrent.com/trials/assess-the-impact-of-insulclock-on-glycemic-variability-and-treatment-compliance-in-uncontrolled-dm1-patients-15496https://curecurrent.com/trials/food-based-intervention-rich-in-plant-components-to-improve-metabolic-health-in-prediabetics-fbip-study-15497https://curecurrent.com/trials/effects-of-probiotics-on-gut-microbiota-composition-and-metabolic-outcomes-in-post-gestational-diabetes-women-15498https://curecurrent.com/trials/augmenting-referral-pathway-to-improve-uptake-of-retinal-services-by-diabetic-patients-15499https://curecurrent.com/trials/improve-timely-referral-flow-and-compliance-of-diabetic-retinopathy-patients-15500https://curecurrent.com/trials/early-stage-retinal-abnormalities-in-type-1-diabetes-screened-with-oct-angiography-15501https://curecurrent.com/trials/concurrent-subcutaneous-basal-insulin-and-intravenous-insulin-pump-in-hyperglycemic-crisis-patients-under-critical-care-15502https://curecurrent.com/trials/association-between-natural-hypoglycemic-foods-and-blood-sugar-level-a-pilot-study-15503https://curecurrent.com/trials/effect-of-weekly-high-dose-vitamin-d3-supplementation-on-the-association-between-circulatory-fgf-23-and-a1c-levels-15504https://curecurrent.com/trials/effect-of-dietary-inflammatory-index-on-inflammatory-markers-and-metabolic-parameters-in-patients-with-type-2-diabetes-m-15505https://curecurrent.com/trials/the-long-term-spill-over-impact-of-covid-19-on-health-and-healthcare-of-people-with-non-communicable-diseases-15506https://curecurrent.com/trials/metabolic-effects-of-exogenous-3-hydroxybutyrate-in-patients-with-type-1-diabetes-and-healthy-controls-15507https://curecurrent.com/trials/amcpr-augmented-medication-cardiopulmonary-resuscitation-trial-for-ohca-15508https://curecurrent.com/trials/the-efficacy-of-guardian-connect-to-modify-lifestyle-in-patients-with-type-2-diabetes-mellitus-15509https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-mk-8521-compared-to-placebo-and-a-diabetes-drug-in-participants-with-type-2-diabetes-15510https://curecurrent.com/trials/intervention-effect-of-canagliflozin-on-prediabetes-in-patients-with-hiv-15511https://curecurrent.com/trials/effect-of-splitting-mealtime-insulin-doses-after-mixed-meals-high-in-fat-and-protein-15512https://curecurrent.com/trials/assessment-of-the-efficacy-of-vitamins-a-and-d-and-oryzanol-fortified-canola-oil-in-adults-with-type-2-diabetes-15513https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-jt-001-add-on-in-paatients-with-type-2-diabetes-mellitus-inadequately-controlled-15514https://curecurrent.com/trials/a-post-marketing-surveillance-study-on-nesinaact-tablet-use-among-type-2-diabetes-mellitus-participants-in-korea-15515https://curecurrent.com/trials/prevalence-incidence-and-characteristics-of-nafld-nash-in-type-1-diabetes-mellitus-15516https://curecurrent.com/trials/prevalence-of-hypertension-in-type-2-diabetes-mellitus-15517https://curecurrent.com/trials/clinical-and-cost-effectiveness-of-different-dressing-materials-in-diabetic-foot-ulcers-15518https://curecurrent.com/trials/an-observational-study-to-assess-the-prevalence-of-heart-failure-in-type-2-diabetes-patients-15519https://curecurrent.com/trials/use-of-ibandronate-in-diabetic-patients-15520https://curecurrent.com/trials/european-paediatric-non-alcoholic-fatty-liver-disease-registry-eu-pnafld-15521https://curecurrent.com/trials/investigation-of-the-effect-of-web-based-education-on-self-care-management-and-family-support-in-women-with-type-2-diabe-15522https://curecurrent.com/trials/voies-d-ql-qualitative-study-on-experiences-of-diabetes-care-delivery-and-planning-15523https://curecurrent.com/trials/handball-based-exercise-and-type-2-diabetes-15524https://curecurrent.com/trials/almonds-and-health-effects-on-metabolism-vascular-function-and-cognition-15525https://curecurrent.com/trials/fenofibrate-versus-curcumin-in-type-2-diabetic-patients-15526https://curecurrent.com/trials/comparison-of-csii-and-mdi-in-pediatric-patients-with-type-1-diabetes-15527https://curecurrent.com/trials/a-double-blind-study-to-investigate-efficacy-safety-and-tolerability-of-bay1142524-in-patients-with-type-ii-diabetes-and-15528https://curecurrent.com/trials/the-effect-of-music-therapy-on-pain-and-anxiety-15529https://curecurrent.com/trials/the-effect-of-aromatherapy-on-cognitive-functions-anxiety-and-sleep-15530https://curecurrent.com/trials/effectiveness-of-a-team-based-follow-up-program-in-general-practice-among-people-with-chronic-conditions-15531https://curecurrent.com/trials/fetal-cardiac-remodeling-in-gestational-diabetic-pregnancies-at-the-moment-of-diagnosis-15532https://curecurrent.com/trials/prolonged-fasting-on-glucose-metabolism-and-hormonal-regulation-in-healthy-obese-and-subjects-with-type-2-diabetes-15533https://curecurrent.com/trials/positive-effects-of-daily-consumption-of-bread-enriched-with-hydroxytyrosol-on-the-results-of-a-12-week-dietary-interven-15534https://curecurrent.com/trials/sustainable-east-africa-research-in-community-health-15535https://curecurrent.com/trials/comparison-of-two-oral-hygiene-routines-on-the-glycemic-control-for-type-2-diabetes-patients-with-chronic-periodontitis-15536https://curecurrent.com/trials/effect-of-taking-a-single-tablet-of-iron-on-insulin-secretion-15537https://curecurrent.com/trials/systemic-cross-talk-between-brain-gut-and-peripheral-tissues-in-glucose-homeostasis-effects-of-exercise-training-15538https://curecurrent.com/trials/efficacy-and-safety-of-the-fixed-dose-combination-atorvastatin-fenofibrate-vs-atorvastatin-in-patients-with-t2d-and-dlp-15539https://curecurrent.com/trials/laparascopic-sleeve-gastrectomy-vs-endoscopic-gastric-plication-in-obesity-15540https://curecurrent.com/trials/real-life-evaluation-of-sglt2-use-in-type-1-diabetes-15541https://curecurrent.com/trials/format-of-patient-education-for-different-sociodemographic-groups-15542https://curecurrent.com/trials/does-the-bioactive-substance-in-coffee-cafestol-have-preventive-properties-on-type-2-diabetes-acute-substudy-15543https://curecurrent.com/trials/acute-effects-of-cafestol-on-glucose-metabolism-in-subjects-with-type-2-diabetes-15544https://curecurrent.com/trials/effect-of-adding-dexamethasone-to-intrathecal-bupivacaine-on-blood-sugar-of-patients-undergoing-diabetic-foot-surgeries-15545https://curecurrent.com/trials/effects-of-berberine-plus-inulin-on-diabetes-care-in-patients-with-lada-15546https://curecurrent.com/trials/management-of-patients-with-type-2-diabetes-mellitus-hospitalized-in-internal-medicine-units-minder-study-15547https://curecurrent.com/trials/multi-center-single-arm-observational-study-to-evaluate-the-safety-of-dapagliflozin-in-type-2-diabetes-mellitus-patients-15548https://curecurrent.com/trials/visualisation-of-a-digital-care-pathway-15549https://curecurrent.com/trials/social-support-intervention-for-self-management-of-type-2-diabetes-mellitus-15550https://curecurrent.com/trials/association-between-persistent-organic-pollutants-and-type-2-diabetes-thyroid-cancer-15551https://curecurrent.com/trials/chf6467-sad-and-mad-in-patients-with-diabetic-foot-ulcer-15552https://curecurrent.com/trials/genetic-study-for-infantile-onset-diabetes-mellitus-15553https://curecurrent.com/trials/an-open-label-two-center-randomized-cross-over-study-to-evaluate-the-safety-and-efficacy-of-glycemic-control-using-hybri-15554https://curecurrent.com/trials/skin-stretch-sensory-stimuli-and-tens-in-diabetic-neuropathy-15555https://curecurrent.com/trials/the-evaluation-of-laser-lancing-devices-in-adult-type-2-diabetes-patients-15556https://curecurrent.com/trials/optimisation-of-exercise-intensity-during-high-intensity-interval-training-for-glucose-control-in-prediabetes-15557https://curecurrent.com/trials/effect-of-acute-fructose-load-in-human-15558https://curecurrent.com/trials/glucose-tolerance-and-prevention-of-diabetes-mellitus-type-2-by-polyherbal-formulation-15559https://curecurrent.com/trials/digital-lifestyle-intervention-for-diabetes-pre-diabetes-15560https://curecurrent.com/trials/feasibility-and-acceptability-of-a-complex-intervention-to-improve-initial-medication-adherence-15561https://curecurrent.com/trials/effectiveness-of-tele-exercise-training-on-cardiorespiratory-fitness-in-patients-with-cardiometabolic-multimorbidity-15562https://curecurrent.com/trials/clinical-phenotype-and-outcomes-of-inpatients-with-covid-19-and-diabetes-15563https://curecurrent.com/trials/hesperidin-and-diosmin-effect-on-metabolic-syndrome-15564https://curecurrent.com/trials/ezetimibe-plus-simvastatin-versus-simvastatin-in-patients-with-hypercholesterolemia-and-coronary-risk-factors-p03405-15565https://curecurrent.com/trials/effects-of-proprioceptive-training-in-addition-to-routine-physical-therapy-on-balance-and-quality-of-life-in-patients-wi-15566https://curecurrent.com/trials/effect-of-insulin-staging-in-the-context-of-pharmaceutical-care-on-patients-with-type-2-diabetes-mellitus-15567https://curecurrent.com/trials/automatic-segmentation-ultrasound-based-radiomics-technology-in-diabetic-kidney-disease-15568https://curecurrent.com/trials/diabetes-nutrition-education-with-glycemic-control-15569https://curecurrent.com/trials/establishment-of-the-human-intestinal-and-salivary-microbiota-biobank-diabetes-15570https://curecurrent.com/trials/safety-and-efficacy-of-bc-lispram-15571https://curecurrent.com/trials/correlation-between-nocturnal-oxygen-desaturation-and-glycemic-control-in-diabetic-patients-with-obstructive-sleep-apnea-15572https://curecurrent.com/trials/a-research-study-to-evaluate-the-renal-kidney-protective-effects-of-losartan-in-patients-with-non-insulin-dependent-diab-15573https://curecurrent.com/trials/using-mhealth-mobile-health-to-optimize-glycemic-control-in-adults-with-type-2-diabetes-proof-of-concept-study-15574https://curecurrent.com/trials/randomised-placebo-controlled-study-of-fmt-to-impact-body-weight-and-glycemic-control-in-obese-subjects-with-t2dm-15575https://curecurrent.com/trials/beta-cell-imaging-in-t1d-patients-with-a-different-glycemic-control-15576https://curecurrent.com/trials/personalized-glucose-optimization-through-nutritional-intervention-15577https://curecurrent.com/trials/visualizing-beta-cells-after-islet-transplantation-15578https://curecurrent.com/trials/a-long-term-safety-study-of-tirzepatide-ly3298176-in-participants-with-type-2-diabetes-15579https://curecurrent.com/trials/detection-of-lada-in-a-hospital-in-the-mexican-southeast-15580https://curecurrent.com/trials/steadiset-pilot-study-step-study-15581https://curecurrent.com/trials/post-authorization-safety-study-in-type-2-diabetic-patients-in-saudi-arabia-treated-with-empagliflozin-to-assess-the-inc-15582https://curecurrent.com/trials/pregnancy-outcomes-effects-of-metformin-study-poem-study-15583https://curecurrent.com/trials/cell-therapy-for-diabetic-foot-ulcer-15584https://curecurrent.com/trials/a-trial-on-ophthalmologist-delivered-health-education-on-top-of-routine-community-care-15585https://curecurrent.com/trials/clinical-efficacy-of-insulin-pumps-in-type-1-diabetes-mellitus-patients-in-spain-15586https://curecurrent.com/trials/evaluation-of-the-effect-of-pomegranate-peel-added-bread-on-blood-sugar-fats-and-the-body-s-defense-response-15587https://curecurrent.com/trials/system-accuracy-of-the-blood-glucose-monitor-for-personal-use-jt100-15588https://curecurrent.com/trials/effect-of-breathing-and-relaxation-exercises-on-serum-cortisol-levels-in-type-2-diabetic-patients-15589https://curecurrent.com/trials/ezetimibe-and-simvastatin-in-primary-hypercholesterolemia-diabetes-mellitus-type-2-and-coronary-heart-disease-completed-15590https://curecurrent.com/trials/a-study-of-ly900014-compared-to-insulin-lispro-humalog-in-adults-with-type-2-diabetes-15591https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-pb-201-in-treatment-naive-patients-with-type-2-diabetes-mellitus-15592https://curecurrent.com/trials/the-study-of-recommendation-system-diacompanion-for-women-with-gestational-diabetes-mellitus-15593https://curecurrent.com/trials/subcutaneous-administration-of-teplizumab-in-adults-with-type-1-diabetes-15594https://curecurrent.com/trials/the-effect-of-mobile-application-supported-diabetes-education-on-type-2-diabetes-self-management-and-blood-sugar-level-15595https://curecurrent.com/trials/sleep-apnea-coronary-atherosclerosis-and-heart-failure-in-diabetes-patients-with-nephropathy-15596https://curecurrent.com/trials/balance-and-gait-in-diabetic-neuropathy-15597https://curecurrent.com/trials/assessment-of-efficacy-and-safety-of-thioctic-acid-in-the-oral-treatment-of-symptomatic-diabetic-neuropathy-sydney-2-15598https://curecurrent.com/trials/chilean-maternal-infant-cohort-study-ii-chimincs-ii-15599https://curecurrent.com/trials/type-2-diabetes-and-alteration-of-immune-system-of-intestinal-mucosa-proof-of-concept-15600https://curecurrent.com/trials/long-term-daily-use-of-jardiance-tablets-in-japanese-patients-with-type-2-diabetes-mellitus-15601https://curecurrent.com/trials/decrease-type-ii-diabetes-in-gestational-diabetes-population-15602https://curecurrent.com/trials/investigation-of-the-skin-barrier-in-patients-with-type-1-diabetes-15603https://curecurrent.com/trials/identification-of-biometric-marker-s-capable-of-detecting-early-prediabetes-clinical-trial-1-15604https://curecurrent.com/trials/impact-of-pharmaceutical-education-on-medication-adherence-15605https://curecurrent.com/trials/the-ehealth-diabetes-remission-trial-pilot-study-15606https://curecurrent.com/trials/barom-tre-sant-adulte-2021-2022-15607https://curecurrent.com/trials/incretin-hormone-antagonism-after-bariatric-surgery-15608https://curecurrent.com/trials/the-effect-of-health-education-given-to-prediabetes-patients-by-videoconferencing-on-self-management-and-exercise-15609https://curecurrent.com/trials/effects-on-glucose-homeostasis-of-changes-in-plasma-lipoproteins-induced-by-nutritional-and-pharmacologic-strategies-15610https://curecurrent.com/trials/assessment-of-the-efficacy-of-the-artificial-pancreas-combined-with-a-qualitative-meal-size-estimation-to-control-postpr-15611https://curecurrent.com/trials/correlation-of-vitamin-d-levels-in-early-pregnancy-with-gestational-diabetes-and-pregnancy-outcomes-15612https://curecurrent.com/trials/comparisons-of-metabolic-effect-of-sleeve-gastrectomy-with-duodenojejunal-bypass-and-sleeve-gastrectomy-medusa-a-multice-15613https://curecurrent.com/trials/dna-methylation-and-gene-expression-in-qataris-with-type-2-diabetes-15614https://curecurrent.com/trials/pre-operative-intranasal-oxytocin-for-enhancing-bariatric-induced-diabetes-remission-15615https://curecurrent.com/trials/vitamin-d-supplementation-for-the-prevention-of-gdm-15616https://curecurrent.com/trials/incretin-based-therapy-in-late-preclinical-type-1-diabetes-15617https://curecurrent.com/trials/risk-of-bladder-cancer-in-type-2-diabetes-patients-with-pioglitazone-therapy-probe-15618https://curecurrent.com/trials/incretin-based-therapy-in-preclinical-type-1-diabetes-in-adults-15619https://curecurrent.com/trials/reducing-hypoglycemia-fear-in-parents-of-young-children-with-type-1-diabetes-15620https://curecurrent.com/trials/glycemic-outcomes-and-safety-with-minimed-780g-system-in-children-with-type-1-diabetes-aged-2-6-years-15621https://curecurrent.com/trials/comparison-of-cognitive-and-motor-dual-task-performance-in-individuals-with-prediabetes-and-diabetes-15622https://curecurrent.com/trials/endocrine-changes-and-their-correction-in-heart-and-lung-transplant-recipients-and-donors-15623https://curecurrent.com/trials/post-healing-follow-up-study-in-people-with-remission-of-a-diabetic-foot-ulcer-15624https://curecurrent.com/trials/cardiovascular-effects-of-exercise-related-hypoglycaemia-in-patients-with-type-1-diabetes-hypo-heart-exercise-15625https://curecurrent.com/trials/the-risk-factors-of-cardiovascular-disease-in-elderly-diabetic-patients-a-prospective-cohort-study-15626https://curecurrent.com/trials/assessing-the-impact-of-control-iq-technology-15627https://curecurrent.com/trials/effect-of-oat-compounds-on-postprandial-glucose-response-15628https://curecurrent.com/trials/vasopressin-and-steroids-in-addition-to-adrenaline-in-cardiac-arrest-a-randomized-clinical-trial-15629https://curecurrent.com/trials/pelvic-girdle-pain-in-pregnant-women-15630https://curecurrent.com/trials/gestational-diabetes-management-based-on-planned-behavior-theory-15631https://curecurrent.com/trials/glucose-lowering-effects-and-safety-of-adding-0-25-or-0-5-mg-duvie-15632https://curecurrent.com/trials/assessing-the-feasibility-and-acceptability-of-a-virtual-food-skills-program-for-children-with-type-1-diabetes-during-co-15633https://curecurrent.com/trials/study-for-beinaglutide-versus-glargine-therapy-in-glycemic-variability-of-type-2-diabetes-mellitus-15634https://curecurrent.com/trials/clinical-trial-with-broccoli-sprout-extract-to-patients-with-type-2-diabetes-15635https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-balloon-catheter-combined-with-oxytocin-induction-in-nulliparous-women-with-estim-15636https://curecurrent.com/trials/kidney-fat-in-type-2-diabetes-and-the-effects-of-ezetimibe-15637https://curecurrent.com/trials/anti-diabetic-drugs-and-fatty-liver-management-15638https://curecurrent.com/trials/hypoglycaemia-and-cardiac-arrhythmias-in-type-1-diabetes-15639https://curecurrent.com/trials/renal-actions-of-combined-empagliflozin-and-linagliptin-in-type-2-diabetes-15640https://curecurrent.com/trials/shivering-and-glucose-homeostasis-15641https://curecurrent.com/trials/screening-for-gdm-in-women-with-pcos-and-controls-15642https://curecurrent.com/trials/diabetes-risk-diagnosis-and-management-15643https://curecurrent.com/trials/online-self-learning-for-women-with-gestational-diabetes-mellitus-15644https://curecurrent.com/trials/motivational-interviewing-with-diabetes-patients-15645https://curecurrent.com/trials/incretin-based-therapy-in-early-diagnosed-type-1-diabetes-15646https://curecurrent.com/trials/effects-of-empagliflozin-on-exercise-capacity-and-left-ventricular-diastolic-function-in-patients-with-heart-failure-wit-15647https://curecurrent.com/trials/daily-vs-intermittent-restriction-of-energy-controlled-trial-to-reduce-diabetes-risk-direct-15648https://curecurrent.com/trials/a-study-of-ly3457263-in-healthy-participants-and-participants-with-type-2-diabetes-15649https://curecurrent.com/trials/effects-of-epalrestat-on-peripheral-neuropathy-and-central-nervous-system-in-diabetic-patients-15650https://curecurrent.com/trials/amputation-associated-factors-and-prediction-model-in-diabetic-foot-patients-15651https://curecurrent.com/trials/assessment-of-an-integrated-continuous-glucose-monitor-and-insulin-injection-port-in-type-2-diabetes-15652https://curecurrent.com/trials/evaluation-of-immunogenicity-and-safety-of-covid-19-vaccine-produced-in-beijing-in-patients-with-hypertension-and-or-dia-15653https://curecurrent.com/trials/gastric-per-oral-endoscopic-myotomy-g-poem-in-refractory-gastroparesis-15654https://curecurrent.com/trials/copenhagen-boston-sydney-15655https://curecurrent.com/trials/diabetic-metabolic-cardiomyopathy-prevalence-and-phenotype-15656https://curecurrent.com/trials/the-application-and-evaluation-of-ehealth-literacy-ehl-concept-15657https://curecurrent.com/trials/triple-combination-therapy-in-type-2-diabetic-patients-who-had-inadequate-glycemic-control-with-combination-therapy-15658https://curecurrent.com/trials/incidence-of-hypoglycemia-in-pregnant-ladies-with-or-without-gestational-diabetes-fasting-ramadan-15659https://curecurrent.com/trials/automated-vs-conventional-perioperative-glycemic-control-in-diabetic-patients-undergoing-cardiopulmonary-bypass-surgery-15660https://curecurrent.com/trials/the-effect-of-exercises-performed-according-to-circadian-rhythm-in-type-2-diabetes-15661https://curecurrent.com/trials/computer-aided-diagnosis-of-multiple-eye-fundus-diseases-from-color-fundus-photograph-15662https://curecurrent.com/trials/additional-insulin-for-high-fat-protein-in-type-1-diabetes-15663https://curecurrent.com/trials/transient-thermal-behavior-and-diabetic-foot-15664https://curecurrent.com/trials/thumb-ecg-incident-atrial-fibrillation-in-diabetes-mellitus-15665https://curecurrent.com/trials/three-day-in-clinic-evaluation-of-the-bd-2nd-generation-continuous-glucose-sensor-device-in-type-1-diabetics-15666https://curecurrent.com/trials/root-cause-determination-of-catheter-obstructions-15667https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-and-pharmacodynamic-characteristics-of-jp-2266-in-healthy-subjects-15668https://curecurrent.com/trials/the-effect-of-exercise-on-quality-of-life-sleep-quality-and-anxiety-in-patients-with-prediabetes-efexquls-15669https://curecurrent.com/trials/explorative-assessment-of-biomarkers-in-overweight-and-obese-subjects-15670https://curecurrent.com/trials/validation-of-the-doubly-labelled-water-method-in-subjects-with-type-2-diabetes-mellitus-15671https://curecurrent.com/trials/efficacy-of-two-schemes-of-self-monitoring-capillary-glucose-in-gestational-diabetes-15672https://curecurrent.com/trials/efficacy-of-treatment-for-gestational-diabetes-diagnosed-by-the-iadpsg-criteria-15673https://curecurrent.com/trials/effect-of-primary-non-surgical-endodontic-therapy-on-glycaemic-control-in-type-2-diabetic-patients-with-asymptomatic-api-15674https://curecurrent.com/trials/the-dose-effects-of-isomaltulose-and-sucrose-on-glycaemic-and-insulinemic-response-15675https://curecurrent.com/trials/dario-blood-glucose-monitoring-system-user-performance-evaluation-15676https://curecurrent.com/trials/healthcare-transition-of-adolescents-with-chronic-health-conditions-15677https://curecurrent.com/trials/neuropsychiatric-factors-15678https://curecurrent.com/trials/android-artificial-pancreas-system-android-aps-versus-control-iq-15679https://curecurrent.com/trials/low-level-laser-therapy-for-the-treatment-of-diabetic-foot-ulcer-15680https://curecurrent.com/trials/perioperative-closed-loop-glucose-control-15681https://curecurrent.com/trials/glucose-stimulated-pancreatic-islet-and-intestinal-blood-flow-in-healthy-subjects-and-in-type-1-diabetes-15682https://curecurrent.com/trials/a-study-of-ly3537021-in-healthy-participants-and-participants-with-type-2-diabetes-mellitus-15683https://curecurrent.com/trials/effect-of-web-based-education-on-gestational-diabetes-mellitus-and-health-management-self-efficacy-15684https://curecurrent.com/trials/effects-of-nursing-diabetes-self-management-education-15685https://curecurrent.com/trials/efficacy-of-closed-loop-insulin-therapy-in-prepubertal-child-in-free-life-15686https://curecurrent.com/trials/efficacy-of-closed-loop-insulin-therapy-in-adults-prone-to-hypoglycemia-15687https://curecurrent.com/trials/study-to-investigate-the-effect-of-dietary-fibre-supplementation-on-long-term-glucose-control-in-prediabetic-subjects-15688https://curecurrent.com/trials/dapagliflozin-effect-on-erythropoiesis-and-physical-fitness-15689https://curecurrent.com/trials/biodex-balance-system-training-in-diabetic-neuropathy-15690https://curecurrent.com/trials/laser-therapy-for-at-home-treatment-of-diabetic-foot-ulcers-15691https://curecurrent.com/trials/copeptin-for-prediction-of-treatment-response-in-children-with-monosymptomatic-nocturnal-enuresis-men-15692https://curecurrent.com/trials/self-management-of-type-1-diabetes-under-functional-insulin-therapy-15693https://curecurrent.com/trials/effects-of-home-based-resistance-exercise-on-body-composition-muscle-strength-and-glycemic-control-in-people-with-type-2-15694https://curecurrent.com/trials/efficacy-and-safety-of-evogliptin-when-added-to-ongoing-metformin-and-dapagliflozin-combination-therapy-in-patients-with-15695https://curecurrent.com/trials/maternal-diabetes-in-newborns-with-hearing-loss-15696https://curecurrent.com/trials/mobile-phone-based-video-education-on-diabetes-15697https://curecurrent.com/trials/study-the-feasibility-of-permanent-use-of-incontrol-for-the-treatment-of-type-1-diabetes-15698https://curecurrent.com/trials/a-trial-of-hr17031-injection-with-hepatic-insufficiency-15699https://curecurrent.com/trials/construction-and-biological-study-of-blood-and-placenta-samples-associated-with-gestational-diabetes-mellitus-15700https://curecurrent.com/trials/awareness-of-gestational-diabetes-among-sohag-governorate-women-15701https://curecurrent.com/trials/a-phase-iv-study-in-drug-naive-patients-with-t2dm-in-china-15702https://curecurrent.com/trials/the-effects-of-tmz-on-diabetic-nephropathy-15703https://curecurrent.com/trials/risk-factors-for-acute-kidney-injury-in-diabetic-patients-15704https://curecurrent.com/trials/pressure-sensing-insoles-in-the-neuropathic-ulcer-treatment-pathway-15705https://curecurrent.com/trials/associations-of-plasma-fatty-acid-patterns-with-gestational-diabetes-mellitus-15706https://curecurrent.com/trials/the-effect-of-a-supervised-home-based-tele-rehabilitation-program-on-patients-with-type-2-diabetes-15707https://curecurrent.com/trials/impact-on-the-oxidative-stress-of-the-different-analogues-of-insulin-in-people-with-type-1-diabetes-ineox-study-15708https://curecurrent.com/trials/identifying-the-effect-and-working-mechanisms-of-myplan-2-0-in-adults-with-type-2-diabetes-15709https://curecurrent.com/trials/insulin-schemes-for-type-2-diabetes-control-15710https://curecurrent.com/trials/effect-of-aqueous-cinnamon-extract-on-the-postprandial-glycaemia-levels-in-type-2-diabetes-mellitus-15711https://curecurrent.com/trials/preoperative-bevacizumab-and-ziv-aflibercept-administration-in-pdr-subjects-undergoing-ppv-15712https://curecurrent.com/trials/system-accuracy-of-the-blood-glucose-monitor-for-personal-use-bg-709b-15713https://curecurrent.com/trials/ilm-peeling-in-pdr-patients-undergoing-ppv-for-vh-15714https://curecurrent.com/trials/treatment-of-ped-with-amt-and-autologous-serum-15715https://curecurrent.com/trials/vitamin-d-supplementation-and-glycemic-control-improvement-among-type-1-diabetic-children-15716https://curecurrent.com/trials/anti-tnf-to-delay-or-prevent-progression-to-stage-3-t1d-15717https://curecurrent.com/trials/silicone-oil-versus-gas-in-pdr-patients-undergoing-vitrectomy-15718https://curecurrent.com/trials/low-carbohydrate-diet-glycaemic-control-and-quality-of-life-in-australian-adults-with-type-1-diabetes-15719https://curecurrent.com/trials/ppv-with-internal-limiting-membrane-peeling-for-treatment-na-ve-dme-15720https://curecurrent.com/trials/glucoach-technology-enabled-lifestyle-intervention-study-15721https://curecurrent.com/trials/analysis-of-faz-in-diabetic-retinopathy-using-oct-angiography-15722https://curecurrent.com/trials/abu-dhabi-diabetes-and-obesity-study-2-bariatric-15723https://curecurrent.com/trials/controlled-outcome-evaluations-of-a-daily-physical-activity-intervention-for-individuals-with-type-2-diabetes-15724https://curecurrent.com/trials/mity-kids-metformin-in-women-with-type-2-diabetes-in-pregnancy-kids-trial-15725https://curecurrent.com/trials/wolffia-globosa-mankai-and-glycemic-control-among-patients-with-type-2-diabetes-15726https://curecurrent.com/trials/csii-versus-mdi-in-pregnant-women-with-type-2-diabetes-15727https://curecurrent.com/trials/preventive-approach-for-the-management-of-the-main-geriatric-risks-15728https://curecurrent.com/trials/effects-of-moderate-physical-activity-on-glycemic-control-in-type-2-diabetes-mellitus-15729https://curecurrent.com/trials/correlation-between-targeted-hba1c-values-and-prevention-of-recurrent-cardiovascular-events-in-type-2-diabetes-after-pci-15730https://curecurrent.com/trials/carbohydrate-counting-and-dash-intervention-among-children-with-diabetes-and-celiac-disease-15731https://curecurrent.com/trials/non-insulino-dependant-diabetes-in-infants-and-teenagers-15732https://curecurrent.com/trials/observational-study-of-glucose-tolerance-abnormalities-in-patient-with-cystic-fibrosis-homozygous-for-phe-508-del-cftr-t-15733https://curecurrent.com/trials/a-study-to-assess-the-effect-of-food-on-hr20033-and-pharmacokinetic-after-multiple-dose-in-healthy-volunteers-15734https://curecurrent.com/trials/sitagliptin-cardiovascular-outcomes-study-mk-0431-082-15735https://curecurrent.com/trials/swemami-dmi-microbiome-15736https://curecurrent.com/trials/a-study-of-adverse-events-and-suspected-adverse-drug-reactions-in-patients-under-apixaban-for-prevention-of-stroke-and-s-15737https://curecurrent.com/trials/effectiveness-of-nutritional-program-among-diabetic-patients-15738https://curecurrent.com/trials/initial-combination-of-gemigliptin-and-metformin-on-microbiota-change-15739https://curecurrent.com/trials/efficacy-and-safety-of-recombinant-human-insulin-patch-zjsrm2021-15740https://curecurrent.com/trials/acute-effect-of-empagliflozin-vs-dapagliflozin-over-pulse-wave-velocity-in-type-two-diabetes-15741https://curecurrent.com/trials/effect-of-tropicamide-0-5-vs-tropicamide-1-on-intraocular-pressure-of-diabetic-patients-15742https://curecurrent.com/trials/autologous-hematopoietic-stem-cell-transplantation-for-early-onset-type-1-diabetes-15743https://curecurrent.com/trials/stability-and-crestal-bone-changes-around-implants-placed-at-crestal-versus-subcrestal-level-in-controlled-type-two-diab-15744https://curecurrent.com/trials/pattern-and-type-of-amputation-and-mortality-rate-associated-with-diabetic-foot-in-jeddah-saudi-arabia-a-retrospective-c-15745https://curecurrent.com/trials/intervention-with-a-gaba-supplement-in-prediabetics-15746https://curecurrent.com/trials/a-research-study-looking-at-how-semaglutide-works-in-people-with-type-2-diabetes-in-denmark-and-sweden-as-part-of-local-15747https://curecurrent.com/trials/efficacy-of-metformin-in-preventing-diabetes-in-china-15748https://curecurrent.com/trials/pharmacokinetic-drug-interaction-between-teneligliptin-and-empagliflozin-15749https://curecurrent.com/trials/neurologic-and-immunologic-characteristics-of-ctla-4-and-lrba-hereditary-deficiency-15750https://curecurrent.com/trials/the-impact-of-a-predictive-hypoglycaemia-alert-function-in-physical-activity-for-people-with-t1dm-15751https://curecurrent.com/trials/microvascular-dysfunction-in-diabetic-peripheral-neuropathy-15752https://curecurrent.com/trials/exploration-of-women-s-experiences-and-technology-usage-before-during-and-after-pregnancy-in-singapore-15753https://curecurrent.com/trials/a-research-study-looking-at-similarity-between-once-weekly-semaglutide-versions-for-different-injection-pens-15754https://curecurrent.com/trials/use-of-closed-loop-insulin-delivery-for-glucose-control-in-patients-with-insulin-dependent-diabetes-mellitus-after-kidne-15755https://curecurrent.com/trials/a-regulatory-post-marketing-surveillance-rpms-study-of-ryzodeg-flextouch-insulin-degludec-insulin-aspart-to-evaluate-saf-15756https://curecurrent.com/trials/a-study-in-adult-patients-with-nonalcoholic-steatohepatitis-who-also-have-type-2-diabetes-15757https://curecurrent.com/trials/effects-of-whey-protein-pre-meals-on-post-prandial-glucose-15758https://curecurrent.com/trials/suspicion-of-hypoglycemic-effect-of-mrna-based-covid-19-vaccines-polyethylene-glycol-will-happen-observational-study-on-15759https://curecurrent.com/trials/breathing-based-leg-resistance-exercise-improves-wound-healing-blood-sugar-and-quality-of-life-for-diabetic-foot-ulcers-15760https://curecurrent.com/trials/lifestyle-intervention-in-chronic-ischemic-heart-disease-and-diabetes-15761https://curecurrent.com/trials/deep-learning-for-fluorescein-angiography-and-optical-coherence-tomography-macular-thickness-map-image-translation-15762https://curecurrent.com/trials/continuous-glucose-monitoring-profile-description-under-alpelisib-treatment-in-patients-with-advanced-breast-cancer-15763https://curecurrent.com/trials/a-study-to-assess-the-bioequivalence-of-fixed-dose-combination-of-hr20033-relative-to-co-administration-of-the-individua-15764https://curecurrent.com/trials/an-observational-study-investigating-the-effectiveness-of-pravastatin-on-renal-function-in-korean-dyslipidemic-patients-15765https://curecurrent.com/trials/effects-of-pcsk9-inhibition-by-evolocumab-on-postprandial-lipid-metabolism-in-type-2-diabetes-15766https://curecurrent.com/trials/cardiovascular-diseases-and-diabetes-prevention-programme-in-metabolic-syndrome-cdpp-15767https://curecurrent.com/trials/evaluation-of-immunogenicity-safety-and-antibody-persistence-of-covid-19-booster-vaccine-produced-in-wuhan-in-patients-w-15768https://curecurrent.com/trials/defining-outcome-measures-for-acute-charcot-neuroarthropathy-in-diabetes-and-their-use-in-assessing-clinical-management-15769https://curecurrent.com/trials/evaluation-of-immunogenicity-safety-and-antibody-persistence-of-covid-19-booster-vaccine-produced-in-beijing-in-patients-15770https://curecurrent.com/trials/relationship-between-oral-health-and-diabetes-15771https://curecurrent.com/trials/a-study-to-assess-the-effectiveness-of-aflibercept-in-routine-clinical-practice-in-patients-with-diabetic-macular-oedema-15772https://curecurrent.com/trials/methods-of-early-detection-and-grading-of-diabetic-peripheral-neuropathy-medon-15773https://curecurrent.com/trials/amnioexcel-plus-vs-soc-in-the-management-of-diabetic-foot-ulcers-15774https://curecurrent.com/trials/intensive-glycemic-control-for-diabetic-foot-ulcer-healing-15775https://curecurrent.com/trials/treatment-of-impending-ulcers-associated-with-hammer-mallet-and-claw-toe-deformities-in-the-diabetic-patient-setting-15776https://curecurrent.com/trials/treatment-of-ulcers-associated-with-hammer-mallet-and-claw-toe-deformities-in-the-diabetic-patient-setting-15777https://curecurrent.com/trials/use-of-procenta-conformable-barrier-for-non-healing-foot-ankle-ulcers-in-patients-with-diabetes-mellitus-types-i-and-ii-15778https://curecurrent.com/trials/intensified-insulin-therapy-with-telemedicine-15779https://curecurrent.com/trials/cardiopulmonary-exercise-test-assessing-multiple-biomarkers-in-type-1-diabetes-15780https://curecurrent.com/trials/to-evaluate-the-safety-tolerability-pk-and-pd-of-xw003-injection-in-healthy-adult-participants-15781https://curecurrent.com/trials/a-guided-self-determination-intervention-versus-attention-control-for-people-with-type-2-diabetes-in-outpatient-clinics-15782https://curecurrent.com/trials/tefa-family-prevention-glutenfree-diet-to-preserve-beta-cell-function-15783https://curecurrent.com/trials/safety-and-feasibility-study-of-autologous-progenitor-cell-transplantation-in-diabetic-neuropathy-15784https://curecurrent.com/trials/drug-related-problems-focus-on-age-and-diabetes-15785https://curecurrent.com/trials/a-community-based-weight-loss-programme-for-chinese-overweight-adults-with-pre-diabetes-15786https://curecurrent.com/trials/evaluation-of-immunogenicity-and-safety-of-covid-19-vaccine-produced-in-wuhan-in-patients-with-hypertension-and-or-diabe-15787https://curecurrent.com/trials/cognitive-behavioral-sleep-intervention-for-prevention-of-type-2-diabetes-15788https://curecurrent.com/trials/a-smartphone-based-intervention-for-diabetes-prevention-in-overweight-chinese-adults-with-pre-diabetes-15789https://curecurrent.com/trials/effects-of-antigravity-treadmill-training-on-gait-and-balance-in-patients-with-diabetic-polyneuropathy-15790https://curecurrent.com/trials/weight-gain-recommendations-for-chinese-women-with-gestational-diabetes-mellitus-15791https://curecurrent.com/trials/adapt-and-incorporate-ddpp-into-clinical-workflows-15792https://curecurrent.com/trials/a-comparative-study-of-brain-structure-and-amyloid-load-in-mci-patients-15793https://curecurrent.com/trials/muscle-multi-parametric-nmr-imaging-development-in-aged-people-with-sarcopenia-or-frailty-syndrome-clinical-study-15794https://curecurrent.com/trials/diaport-closed-loop-artificial-pancreas-15795https://curecurrent.com/trials/personalized-glucose-predictive-and-therapy-advisory-system-diadvisor-2-15796https://curecurrent.com/trials/splanchnic-blood-redistribution-after-incretin-hormone-infusion-and-obesity-surgery-15797https://curecurrent.com/trials/different-initial-insulin-dose-regimens-on-time-to-achieve-glycemic-targets-and-treatment-safety-in-siit-15798https://curecurrent.com/trials/effect-of-whole-body-vibration-training-on-glycemic-control-in-type-ii-diabetic-patients-15799https://curecurrent.com/trials/diabetes-in-relation-to-hospitalized-covid-19-patents-at-assiut-university-hospital-15800https://curecurrent.com/trials/cost-effectiveness-of-the-care-pathways-15801https://curecurrent.com/trials/the-prevalence-of-contact-allergies-for-wound-dressings-in-patients-with-diabetic-foot-ulcers-paid-study-15802https://curecurrent.com/trials/a-multi-center-prospective-observational-study-to-describe-the-situation-of-blood-lipid-management-among-the-population-15803https://curecurrent.com/trials/the-effect-of-glucose-level-and-diabetes-mellitus-on-ctrough-of-olaparib-15804https://curecurrent.com/trials/longterm-follow-up-of-subjects-with-diabetes-2-type-treatment-with-ex-vivo-gene-therapy-15805https://curecurrent.com/trials/the-effect-of-d-allulose-on-the-glycemic-changes-in-patients-with-type-2-diabetes-mellitus-during-ramadan-fasting-15806https://curecurrent.com/trials/effect-of-a-nss-to-reduce-complications-in-patients-with-covid-19-and-comorbidities-in-stage-iii-15807https://curecurrent.com/trials/safety-of-preoperative-carbohydrate-loading-in-diabetic-patients-15808https://curecurrent.com/trials/blood-glucose-monitoring-systems-discounter-versus-brand-15809https://curecurrent.com/trials/treatment-of-chronic-wounds-in-diabetic-foot-syndrome-with-allogeneic-adipose-derived-mesenchymal-stem-cells-15810https://curecurrent.com/trials/multiomics-based-prediction-model-for-gdm-15811https://curecurrent.com/trials/glp-1-mediated-gluco-metabolic-effects-of-bile-acid-sequestration-15812https://curecurrent.com/trials/educational-intervention-targeting-statin-therapy-and-compliance-in-diabetic-patients-15813https://curecurrent.com/trials/variation-of-genes-controlling-carbohydrate-and-lipid-metabolism-15814https://curecurrent.com/trials/abu-dhabi-diabetes-and-obesity-study-15815https://curecurrent.com/trials/dundrum-forensic-redevelopment-evaluation-study-d-forest-study-15816https://curecurrent.com/trials/diabetic-cardiomyopathy-15817https://curecurrent.com/trials/long-term-outcomes-of-chronic-hepatitis-c-patients-post-sofosbuvir-based-treatment-15818https://curecurrent.com/trials/metformin-and-sitagliptin-therapy-for-adult-patients-with-type-2-diabetes-admitted-to-the-general-medical-unit-15819https://curecurrent.com/trials/glycemic-index-variations-in-the-early-period-following-bariatric-surgery-15820https://curecurrent.com/trials/hypoglycemia-prediction-model-15821https://curecurrent.com/trials/safety-and-efficacy-of-ema401-in-patients-with-painful-diabetic-neuropathy-pdn-15822https://curecurrent.com/trials/effectiveness-of-the-autologous-adipose-tissue-harvested-with-sefficare-method-for-treatment-of-dfu-minor-amputation-15823https://curecurrent.com/trials/regroup-renohemodynamic-effects-empagliflozin-in-various-populations-15824https://curecurrent.com/trials/renohemodynamic-effects-of-combined-empagliflozin-and-losartan-15825https://curecurrent.com/trials/effects-of-sglt2-inhibitor-on-type-2-diabetic-patients-undergoing-cardiac-surgery-15826https://curecurrent.com/trials/evaluation-of-the-severity-of-cardiovascular-autonomic-neuropathy-in-type-1-diabetic-patients-with-osas-15827https://curecurrent.com/trials/pragmatic-randomized-control-trial-of-telehealth-vs-standard-care-in-follow-up-of-patients-with-chronic-conditions-15828https://curecurrent.com/trials/continuous-glycemia-monitoring-in-perioperative-period-in-patients-undergoing-total-knee-or-hip-arthroplasty-15829https://curecurrent.com/trials/assessment-of-metabolic-profiles-of-lower-extremity-arterial-disease-in-patiens-withe-type-2-diabetes-15830https://curecurrent.com/trials/pregnancy-complications-in-women-with-bmi-25-kg-m2-enrolled-in-a-healthy-lifestyle-and-eating-habits-program-15831https://curecurrent.com/trials/the-impact-of-different-csii-and-cgm-systems-on-different-clinical-outcome-variables-in-children-and-adolescents-with-ty-15832https://curecurrent.com/trials/wearable-technology-and-a-virtual-lifestyle-program-for-type-2-diabetics-15833https://curecurrent.com/trials/modulating-effects-of-oil-palm-phenolics-in-subjects-with-pre-diabetes-15834https://curecurrent.com/trials/a-study-using-the-lmc-diabetes-registry-to-learn-more-about-chronic-kidney-disease-ckd-in-canadian-patients-with-type-2-15835https://curecurrent.com/trials/the-use-of-a-continuous-glucose-monitoring-system-dexcom-g6-in-hospitalized-patients-for-acute-care-15836https://curecurrent.com/trials/the-pharmacokinetics-safety-and-tolerability-of-in-c009-in-healthy-subjects-15837https://curecurrent.com/trials/tertiary-prevention-in-type-ii-diabetes-mellitus-in-canary-islands-study-15838https://curecurrent.com/trials/hepatic-histology-and-metabolism-following-total-pancreatectomy-and-pancreaticoduodenectomy-15839https://curecurrent.com/trials/the-effect-of-single-probiotic-on-metabolic-control-in-type-2-diabetes-15840https://curecurrent.com/trials/macular-involvement-in-diabetic-retinopathy-evaluated-with-swept-source-oct-15841https://curecurrent.com/trials/fast-advanced-closed-loop-therapy-15842https://curecurrent.com/trials/a-study-of-tg103-injection-in-overweight-obese-subjects-with-type-2-diabetes-15843https://curecurrent.com/trials/risk-for-ketonaemia-in-type-1-diabetes-pregnancies-with-sensor-augmented-pump-therapy-15844https://curecurrent.com/trials/ambulance-hypos-can-strike-twice-study-15845https://curecurrent.com/trials/patient-centered-care-in-diabetes-in-ecuador-15846https://curecurrent.com/trials/safety-and-efficacy-study-of-autologous-bone-marrow-aspirate-concentrate-for-no-option-critical-limb-ischemia-15847https://curecurrent.com/trials/the-expression-of-circankrd36-as-a-new-biomarker-of-diabetic-nephropathy-15848https://curecurrent.com/trials/quality-of-life-in-pancreas-transplantation-15849https://curecurrent.com/trials/coronary-artery-calcification-in-type-2-diabetes-mellitus-uscac-study-15850https://curecurrent.com/trials/early-environmental-and-maternal-determinants-of-airway-inflammation-in-wheezing-disorders-in-infants-15851https://curecurrent.com/trials/integration-of-chronic-disease-rehabilitation-services-into-primary-care-15852https://curecurrent.com/trials/is-mg-do-improve-the-glycemic-control-in-patients-drink-a-desalinate-water-15853https://curecurrent.com/trials/predictive-a1c-based-on-cgm-data-using-cgm-data-15854https://curecurrent.com/trials/substitution-of-sulfonylureas-with-new-generation-of-hypoglycemic-drugs-for-the-treatment-of-type-2-diabetes-mellitus-15855https://curecurrent.com/trials/a-study-investigating-the-clinical-parameters-associated-with-the-use-of-ryzodeg-insulin-degludec-insulin-aspart-in-a-re-15856https://curecurrent.com/trials/safety-and-effectiveness-of-low-molecular-weight-sulfated-dextran-in-islet-transplantation-15857https://curecurrent.com/trials/silastic-ring-gastric-bypass-versus-sleeve-gastrectomy-for-type-2-diabetes-mellitus-in-obese-patients-15858https://curecurrent.com/trials/the-effect-of-sitagliptin-treatment-in-covid-19-positive-diabetic-patients-15859https://curecurrent.com/trials/an-8-day-initiation-of-advanced-hybrid-closed-loop-system-in-children-and-adolescents-15860https://curecurrent.com/trials/effects-of-frequency-and-duration-of-exercise-in-people-with-type-1-diabetes-a-randomized-crossover-study-15861https://curecurrent.com/trials/an-observational-clinical-trial-examining-the-effect-of-topical-oxygen-therapy-natrox-on-the-rates-of-healing-of-chronic-15862https://curecurrent.com/trials/effect-of-plant-and-animal-proteins-on-biomarkers-of-colorectal-cancer-and-type-2-diabetes-in-healthy-adults-scenoprot-15863https://curecurrent.com/trials/the-best-timing-of-delivery-in-women-with-gdm-study-15864https://curecurrent.com/trials/efficacy-and-safety-of-premixed-insulin-treatment-in-patients-with-type-2-diabetes-mellitus-15865https://curecurrent.com/trials/a-clinical-research-on-disease-progression-and-intervention-of-chronic-hepatitisb-15866https://curecurrent.com/trials/investigating-genetic-risk-for-type-1-diabetes-15867https://curecurrent.com/trials/a-research-study-looking-at-how-semaglutide-works-in-people-with-type-2-diabetes-in-spain-as-part-of-local-clinical-prac-15868https://curecurrent.com/trials/pain-neuroscience-education-in-diabetic-neuropathy-15869https://curecurrent.com/trials/prevalence-of-metabolic-liver-diseases-in-patients-with-type-1-diabetes-mellitus-15870https://curecurrent.com/trials/baseline-blood-indices-and-prolonged-length-of-hospital-stay-15871https://curecurrent.com/trials/a-research-study-looking-at-how-xultophy-works-in-people-with-type-2-diabetes-in-local-clinical-practice-in-united-arab-15872https://curecurrent.com/trials/study-of-insulin-pump-discontinuation-in-adults-with-diabetes-15873https://curecurrent.com/trials/safety-and-efficacy-of-empagliflozin-for-patients-with-diabetes-mellitus-and-planned-percutaneous-coronary-interventions-15874https://curecurrent.com/trials/the-effect-of-remote-smbg-combined-with-the-application-of-app-on-the-improvement-of-t2dm-management-in-the-community-15875https://curecurrent.com/trials/preventing-risk-for-metabolic-syndrome-in-workaholics-an-intervention-15876https://curecurrent.com/trials/a-clinical-study-of-insulin-degludec-injection-in-subjects-with-type-2-diabetes-15877https://curecurrent.com/trials/the-glow-study-the-yang-system-15878https://curecurrent.com/trials/can-mysugr-app-improve-knowledge-and-self-management-of-people-with-type-1-diabetes-mellitus-15879https://curecurrent.com/trials/a-study-of-supaglutide-in-chinese-type-2-diabetes-patients-15880https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-supaglutide-in-healthy-participants-15881https://curecurrent.com/trials/comparison-dry-foot-skin-between-diabetic-and-non-diabetic-subjects-and-the-effects-of-two-cosmetic-foot-care-products-15882https://curecurrent.com/trials/personalized-follow-up-program-in-the-type-2-diabetes-prevention-15883https://curecurrent.com/trials/effect-of-sea-grapes-antioxidants-extract-in-obese-men-4-weeks-randomized-double-blind-controlled-trial-15884https://curecurrent.com/trials/hit-on-hypoglycaemic-risk-in-t1d-15885https://curecurrent.com/trials/diabetic-neuropathy-screening-study-1-1-substudy-1-2-1-3-1-4-15886https://curecurrent.com/trials/retrospective-study-to-evaluate-the-safety-of-duvie-in-korean-patients-with-type-2-diabetes-mellitus-15887https://curecurrent.com/trials/study-with-two-capsaicin-topic-treatments-in-diabetic-neuropathy-15888https://curecurrent.com/trials/negative-pressure-wound-therapy-in-diabetic-wounds-15889https://curecurrent.com/trials/evaluation-of-an-mhealth-behavioural-intervention-for-the-self-management-for-type-2-diabetes-15890https://curecurrent.com/trials/the-interaction-between-protein-intake-gut-microbiota-and-type-2-diabetes-in-subjects-with-different-ethnic-backgrounds-15891https://curecurrent.com/trials/comparison-of-the-patients-with-diabetes-mellitus-using-either-insulin-or-oral-antidiabetic-drug-in-terms-of-difficult-l-15892https://curecurrent.com/trials/management-of-fracture-ankle-in-adults-with-uncontrolled-diabetes-by-hind-foot-nail-with-versus-without-joint-preparatio-15893https://curecurrent.com/trials/a-french-study-to-evaluate-the-usefulness-of-an-implantable-continuous-glucose-monitoring-cgm-sensor-to-improve-glycemic-15894https://curecurrent.com/trials/effects-of-homocysteine-in-myocardial-infarction-patients-in-a-tertiary-care-hospital-of-pakistan-15895https://curecurrent.com/trials/screening-and-management-of-high-risk-populations-of-stroke-in-dehui-city-15896https://curecurrent.com/trials/interstitial-fluid-in-the-development-of-cardiovascular-disease-15897https://curecurrent.com/trials/oral-antidiabetics-effect-on-visceral-fat-15898https://curecurrent.com/trials/association-of-amyloid-40-and-42-with-prediabetes-15899https://curecurrent.com/trials/canakinumab-in-patients-with-covid-19-and-type-2-diabetes-15900https://curecurrent.com/trials/combined-western-and-traditional-chinese-medicine-daycare-for-dm-nephropathy-patients-15901https://curecurrent.com/trials/long-acting-insulin-versus-multiple-dose-regimen-for-control-of-gestational-diabetes-mellitus-15902https://curecurrent.com/trials/quality-of-the-management-of-diabetes-in-elderly-people-with-dementia-in-france-15903https://curecurrent.com/trials/a-research-study-looking-at-how-semaglutide-works-in-people-with-type-2-diabetes-in-canada-as-part-of-local-clinical-pra-15904https://curecurrent.com/trials/china-diabetes-cardiovascular-initiative-15905https://curecurrent.com/trials/freestyle-libre-and-hospital-admissions-in-type-2-diabetes-15906https://curecurrent.com/trials/sglt-2-inhibitors-in-prevention-of-post-procedural-renal-and-cardiovascular-complications-after-pci-among-patients-with-15907https://curecurrent.com/trials/optical-coherence-tomography-morphologic-and-fractional-flow-reserve-assessment-in-diabetes-mellitus-patients-15908https://curecurrent.com/trials/comparison-of-the-fgm-profiles-in-patients-of-type-2-diabetes-treated-with-sitagliptin-and-acarbose-15909https://curecurrent.com/trials/thermal-biofeedback-for-the-treatment-of-diabetic-neuropathy-15910https://curecurrent.com/trials/cicletanine-in-hypertension-with-diabetes-added-magnesium-preserves-potassium-and-sodium-15911https://curecurrent.com/trials/comparative-interventional-study-to-evaluate-the-role-of-lrygbp-lsg-smm-15912https://curecurrent.com/trials/testing-for-arterial-disease-in-diabetes-tread-study-15913https://curecurrent.com/trials/preg-offspring-investigation-of-children-from-mothers-with-and-without-gestational-diabetes-15914https://curecurrent.com/trials/effect-of-f-prausnitzii-on-glycemic-control-15915https://curecurrent.com/trials/role-of-obstructive-sleep-apnea-syndrome-in-the-occurrence-of-diabetic-retinopathy-in-type-2-diabetes-15916https://curecurrent.com/trials/determinants-of-bone-and-muscle-quality-and-strength-in-obesity-with-and-without-diabetes-15917https://curecurrent.com/trials/the-clinical-study-of-the-effect-of-highland-barley-diet-on-blood-glucose-in-patients-with-type-2-diabetes-mellitus-15918https://curecurrent.com/trials/exercise-promotion-in-primary-care-15919https://curecurrent.com/trials/effect-of-walking-exercise-training-on-adherence-to-disease-management-and-metabolic-control-in-diabetes-15920https://curecurrent.com/trials/abnormal-structure-and-bone-density-in-diabetes-15921https://curecurrent.com/trials/pemf-therapy-for-the-management-of-diabetes-in-obese-patients-15922https://curecurrent.com/trials/nafld-among-patients-with-type-2-diabetes-and-ckd-15923https://curecurrent.com/trials/comparison-of-safety-and-efficacy-of-needle-free-injector-and-insulin-pen-in-patients-with-t2dm-15924https://curecurrent.com/trials/novel-method-of-pancreatic-islet-transplantation-into-the-omentum-15925https://curecurrent.com/trials/human-bioequivalence-test-of-liraglutide-injection-15926https://curecurrent.com/trials/effectiveness-and-cost-effectiveness-of-a-telemonitoring-program-for-diabetic-people-at-home-15927https://curecurrent.com/trials/self-management-of-type-2-diabetes-using-a-mobile-application-15928https://curecurrent.com/trials/study-to-evaluate-a-prototype-non-invasive-bg-measurement-system-15929https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-the-exposure-of-the-trial-drug-in-the-body-and-pharmacody-15930https://curecurrent.com/trials/the-use-of-short-sms-messaging-with-type-2-diabetes-t2dm-15931https://curecurrent.com/trials/effectiveness-of-the-health-care-ceo-app-for-t1d-15932https://curecurrent.com/trials/influence-of-a-multi-parametric-optimization-strategy-for-general-anesthesia-on-postoperative-morbidity-and-mortality-15933https://curecurrent.com/trials/the-progress-of-diabetes-mellitus-after-hms5552-treatment-in-type-2-diabetes-mellitus-15934https://curecurrent.com/trials/long-term-efficacy-and-safety-of-hms5552-in-t2dm-subjects-15935https://curecurrent.com/trials/comparison-of-a-new-technique-of-measure-of-the-insulin-resistance-by-scintigraphy-with-the-reference-technique-15936https://curecurrent.com/trials/long-term-efficacy-and-safety-of-hms5552-add-on-to-metformin-in-t2dm-subjects-15937https://curecurrent.com/trials/non-diabetic-causes-of-chronic-kidney-disease-in-type-2-diabetic-patients-15938https://curecurrent.com/trials/efficacy-and-safety-of-ckd-501-added-to-d150-plus-d745-10mg-therapy-in-patients-with-type-2-diabetes-15939https://curecurrent.com/trials/a-study-of-ly900014-versus-insulin-lispro-humalog-on-high-blood-sugar-in-participants-with-type-1-diabetes-who-use-insul-15940https://curecurrent.com/trials/psychological-online-training-to-optimize-adherence-in-patients-with-type-ii-diabetes-15941https://curecurrent.com/trials/evaluate-the-drug-drugs-interaction-between-lobeglitazone-0-5mg-and-empagliflozin-25mg-15942https://curecurrent.com/trials/safety-tolerability-and-renal-effects-of-apx-115-in-subjects-with-type-2-diabetes-and-nephropathy-15943https://curecurrent.com/trials/metabolic-effects-of-melatonin-treatment-15944https://curecurrent.com/trials/a-research-study-looking-at-how-tresiba-works-in-people-with-type-2-diabetes-in-local-clinical-practice-in-russia-15945https://curecurrent.com/trials/european-trial-of-immunosuppression-in-spk-tx-15946https://curecurrent.com/trials/the-singapore-chinese-health-study-15947https://curecurrent.com/trials/the-effect-of-different-states-of-lipid-in-food-on-glycaemia-lipaemia-and-insulinaemia-15948https://curecurrent.com/trials/effect-of-rvx000222-on-time-to-major-adverse-cardiovascular-events-in-high-risk-t2dm-subjects-with-cad-15949https://curecurrent.com/trials/the-effect-of-degree-of-rice-polishing-on-glycaemic-response-15950https://curecurrent.com/trials/participant-reported-outcomes-with-the-accu-chek-solo-micropump-system-15951https://curecurrent.com/trials/digital-tools-for-learning-diabetes-combination-of-animation-and-gamification-15952https://curecurrent.com/trials/effects-of-different-types-of-carbohydrates-in-snacks-and-beverages-on-glycemia-insulinemia-and-appetite-15953https://curecurrent.com/trials/effect-of-sea-weed-ecklonia-cava-extract-on-blood-glucose-and-insulin-level-on-pre-diabetic-patients-15954https://curecurrent.com/trials/vitamin-k-supplementation-to-reduce-deficiencies-in-adults-with-cystic-fibrosis-15955https://curecurrent.com/trials/characteristics-of-young-onset-diabetes-in-sub-saharan-africa-yoda-study-15956https://curecurrent.com/trials/resistance-training-in-patients-with-diabetic-neuropathy-15957https://curecurrent.com/trials/effects-of-2-weeks-treatment-with-dapagliflozin-in-subjects-with-an-impaired-glucose-homeostasis-on-nocturnal-substrate-15958https://curecurrent.com/trials/balance-training-in-diabetic-neuropathy-15959https://curecurrent.com/trials/imaging-vs-no-testing-in-asymptomatic-high-risk-diabetic-patients-15960https://curecurrent.com/trials/interaction-between-omeprazole-and-gliclazide-in-cyp2c19-normal-ultrarapid-metabolisers-15961https://curecurrent.com/trials/evaluation-of-a-treatment-and-education-programme-for-type-1-diabetic-patients-primas-15962https://curecurrent.com/trials/dreamed-advisor-pro-system-in-subjects-with-type-1-diabetes-treated-with-mdi-therapy-15963https://curecurrent.com/trials/quality-of-life-in-patients-with-chronic-disease-15964https://curecurrent.com/trials/effect-of-cpl-2009-0031-in-the-treatment-of-patients-with-uncontrolled-type-2-diabetes-mellitus-15965https://curecurrent.com/trials/learning-modality-in-individuals-with-diabetes-incompatible-15966https://curecurrent.com/trials/acceptance-and-value-based-methods-in-increasing-wellbeing-of-adolescents-with-type-1-diabetes-15967https://curecurrent.com/trials/exercise-intervention-combined-with-metformin-in-the-treatment-of-type-2-diabetes-15968https://curecurrent.com/trials/digitalized-management-exploration-for-gestational-diabetes-mellitus-in-china-15969https://curecurrent.com/trials/supplemented-low-protein-diet-and-progression-of-ckd-15970https://curecurrent.com/trials/establishment-and-preliminary-evaluation-of-digital-three-level-linkage-whole-process-diabetes-management-system-15971https://curecurrent.com/trials/the-effectiveness-of-using-a-mobile-application-for-type-2-diabetes-self-care-15972https://curecurrent.com/trials/tdcs-and-pain-associated-with-diabetic-neuropathy-15973https://curecurrent.com/trials/impact-of-obesity-chronic-kidney-disease-and-type-2-diabetes-on-human-urinary-stem-cells-15974https://curecurrent.com/trials/treatment-of-diabetic-neuropathy-with-liraglutide-15975https://curecurrent.com/trials/the-impact-of-a-diabetes-risk-prediction-model-in-primary-care-15976https://curecurrent.com/trials/diabetes-type-one-in-pregnancy-and-continuos-glucose-monitoring-15977https://curecurrent.com/trials/intra-myometrial-vasopressin-during-cesarean-section-in-placenta-previa-15978https://curecurrent.com/trials/the-influence-of-personality-characteristics-and-emotions-on-blood-glucose-levels-among-type-1-diabetes-mellitus-patient-15979https://curecurrent.com/trials/first-steps-study-of-type-1-in-early-childhood-and-parenting-support-15980https://curecurrent.com/trials/swidinep-a-swiss-diabetic-nephropathy-cohort-15981https://curecurrent.com/trials/as-oct-study-in-diabetic-retinopathy-15982https://curecurrent.com/trials/effect-of-transcutaneous-electrical-nerve-stimulation-in-diabetic-neuropathy-15983https://curecurrent.com/trials/effects-of-dietary-and-weight-management-on-pregnancy-outcomes-in-mobile-medical-platform-15984https://curecurrent.com/trials/the-effect-of-probiotics-on-type-1-diabetes-mellitus-in-children-15985https://curecurrent.com/trials/glycemic-response-to-two-doses-of-low-sugar-apple-juice-15986https://curecurrent.com/trials/effects-of-yogurt-with-probiotics-in-adults-with-type-2-diabetes-mellitus-15987https://curecurrent.com/trials/quality-of-life-and-fixed-ratio-combination-of-insulin-degludec-and-liraglutide-ideglira-15988https://curecurrent.com/trials/toujeo-versus-nph-self-titration-study-15989https://curecurrent.com/trials/the-effect-of-oral-probiotics-on-glycemic-control-of-women-with-gestational-diabetes-mellitus-15990https://curecurrent.com/trials/prevention-in-community-clinics-from-diabetic-kidney-disease-15991https://curecurrent.com/trials/the-effects-of-sglti-on-diabetic-cardiomyopathy-15992https://curecurrent.com/trials/a-study-to-investigate-the-pk-and-safety-of-ckd-393-15993https://curecurrent.com/trials/effect-of-type-1-diabetes-on-sleep-fragmentation-15994https://curecurrent.com/trials/characteristic-and-modulation-of-gut-microbiota-on-the-consequences-of-pregnancy-15995https://curecurrent.com/trials/diabetic-retinopathy-effects-of-melatonin-treatment-on-visual-functions-and-circadian-rhythm-15996https://curecurrent.com/trials/is-the-artificial-pancreas-without-carbohydrate-counting-efficient-and-safe-in-an-outpatient-setting-15997https://curecurrent.com/trials/diabetes-complications-and-the-risk-of-cardiovascular-and-cerebrovascular-diseases-15998https://curecurrent.com/trials/descriptive-analysis-of-long-and-intermediate-acting-insulin-in-adult-diabetics-15999https://curecurrent.com/trials/efficacy-and-safety-of-bifidobacterium-quadruple-live-tablets-in-patients-with-t2dm-and-constipation-16000